Culp (CULP) 10-Q 8 Dec 17 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	6 Months Ended
	Oct. 29, 2017shares
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 29, 2017
Document Fiscal Year Focus	2,018
Document Fiscal Period Focus	Q2
Trading Symbol	CULP
Entity Registrant Name	CULP INC
Entity Central Index Key	723,603
Current Fiscal Year End Date	--04-29
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding	12,435,276

CONSOLIDATED STATEMENTS OF NET

CONSOLIDATED STATEMENTS OF NET INCOME (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
Income Statement [Abstract]
Net sales	$ 80,698	$ 75,343	$ 160,230	$ 156,026
Cost of sales	64,894	58,442	127,962	120,705
Gross profit	15,804	16,901	32,268	35,321
Selling, general and administrative expenses	9,415	9,602	18,916	19,348
Income from operations	6,389	7,299	13,352	15,973
Interest expense	37		37
Interest income	(128)	(15)	(259)	(40)
Other expense	321	155	674	307
Income before income taxes	6,159	7,159	12,900	15,706
Income taxes	2,108	2,684	3,748	5,917
Loss from investment in unconsolidated joint venture	75		193
Net income	$ 3,976	$ 4,475	$ 8,959	$ 9,789
Net income per share, basic	$ 0.32	$ 0.36	$ 0.72	$ 0.80
Net income per share, diluted	$ 0.32	$ 0.36	$ 0.71	$ 0.78
Average shares outstanding, basic	12,440	12,308	12,420	12,297
Average shares outstanding, diluted	12,580	12,507	12,613	12,495

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 3,976	$ 4,475	$ 8,959	$ 9,789
Unrealized gains on investments
Unrealized holding gains on investments	20	4	64	88
Reclassification adjustment for realized loss included in net income				12
Total other comprehensive income	20	4	64	100
Comprehensive income	$ 3,996	$ 4,479	$ 9,023	$ 9,889

CONSOLIDATED BALANCE SHEETS (UN

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands		Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Current assets:
Cash and cash equivalents		$ 15,739	$ 20,795	[1]	$ 13,910
Short-term investments - Available for Sale		2,478	2,443	[1]	2,430
Short-term investments - Held-To-Maturity		4,015
Accounts receivable, net		24,220	24,577	[1]	19,039
Inventories		50,209	51,482	[1]	45,954
Other current assets		2,263	2,894	[1]	1,675
Total current assets		98,924	102,191	[1]	83,008
Property, plant and equipment, net		52,530	51,651	[1]	45,537
Goodwill		11,462	11,462	[1]	11,462
Deferred income taxes		491	419	[1]	581
Long-term investments - Held-To-Maturity		26,853	30,945	[1]	31,050
Long-term investments - Rabbi Trust		6,921	5,466	[1]	4,994
Investment in unconsolidated joint venture		1,522	1,106	[1]
Other assets		2,340	2,394	[1]	2,495
Total assets		201,043	205,634	[1]	179,127
Current liabilities:
Accounts payable-trade		24,600	29,101	[1]	20,183
Accounts payable - capital expenditures		3,209	4,767	[1]	3,000
Accrued expenses		7,364	11,947	[1]	8,878
Income taxes payable - current		692	287	[1]	513
Total current liabilities		35,865	46,102	[1]	32,574
Accounts payable - capital expenditures	[1]		1,322
Income taxes payable - long-term		487	467	[1]	3,734
Deferred income taxes		4,641	3,593	[1]	1,699
Deferred compensation		6,970	5,520	[1]	5,171
Total liabilities		47,963	57,004	[1]	43,178
Commitments and Contingencies (Note 15)				[1]
Shareholders' equity
Preferred stock, $0.05 par value, authorized 10,000,000				[1]
Common stock, $0.05 par value, authorized 40,000,000 shares, issued and outstanding 12,435,276 at October 29, 2017; 12,311,756 at October 30, 2016; and 12,356,631 at April 30, 2017		622	618	[1]	615
Capital contributed in excess of par value		47,441	47,415	[1]	45,349
Accumulated earnings		104,957	100,601	[1]	90,029
Accumulated other comprehensive income (loss)		60	(4)	[1]	(44)
Total shareholders' equity		153,080	148,630	[1]	135,949
Total liabilities and shareholders' equity		$ 201,043	$ 205,634	[1]	$ 179,127
[1]	Derived from audited financial statements.

CONSOLIDATED BALANCE SHEETS (U5

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Oct. 29, 2017	Apr. 30, 2017	[1]	Oct. 30, 2016
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.05	$ 0.05		$ 0.05
Preferred stock, authorized shares	10,000,000	10,000,000		10,000,000
Common stock, par value	$ 0.05	$ 0.05		$ 0.05
Common stock, authorized shares	40,000,000	40,000,000		40,000,000
Common stock, issued	12,435,276	12,356,631		12,311,756
Common stock, outstanding	12,435,276	12,356,631		12,311,756
[1]	Derived from audited financial statements.

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Oct. 29, 2017		Oct. 30, 2016
Cash flows from operating activities:
Net income	$ 8,959		$ 9,789
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	3,713		3,511
Amortization of other assets	166		80
Stock-based compensation	1,558		1,657
Deferred income taxes	976		2,121
Realized loss on sale of short-term investments (Available for Sale)			12
Loss on sale of equipment			9
Loss from investment in unconsolidated joint venture	193
Foreign currency exchange loss (gain)	42		(53)
Changes in assets and liabilities:
Accounts receivable	561		4,142
Inventories	1,597		219
Other current assets	723		751
Other assets	(35)
Accounts payable - trade	(5,074)		(3,274)
Accrued expenses and deferred compensation	(3,607)		(2,469)
Income taxes	406		554
Net cash provided by operating activities	10,178		17,049
Cash flows from investing activities:
Capital expenditures	(4,978)		(6,308)
Investment in unconsolidated joint venture	(609)
Proceeds from the sale of equipment	6
Proceeds from the sale of short-term investments - (Available for Sale)			2,000
Purchase of short-term investments - (Available for Sale)	(24)		(23)
Purchase of long-term investments (Held-To-Maturity)			(31,050)
Proceeds from the sale of long-term investments (Rabbi Trust)	54
Purchase of long-term investments (Rabbi Trust)	(1,457)		(929)
Net cash used in investing activities	(7,008)		(36,310)
Cash flows from financing activities:
Proceeds from line of credit	10,000		7,000
Payments on line of credit	(10,000)		(7,000)
Payments on vendor-financed capital expenditures	(2,500)
Dividends paid	(4,603)		(4,307)
Common stock surrendered for withholding taxes payable	(1,147)		(280)
Payments on debt issuance costs			(2)
Proceeds from common stock issued	5		11
Net cash used in financing activities	(8,245)		(4,578)
Effect of exchange rate changes on cash and cash equivalents	19		(38)
Decrease in cash and cash equivalents	(5,056)		(23,877)
Cash and cash equivalents at beginning of period	20,795	[1]	37,787
Cash and cash equivalents at end of period	$ 15,739		$ 13,910
[1]	Derived from audited financial statements.

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands		Total	Common Stock	Capital Contributed in Excess of Par Value	Accumulated Earnings	Accumulated Other Comprehensive (Loss) Income
Balance at May. 01, 2016		$ 128,812	$ 614	$ 43,795	$ 84,547	$ (144)
Balance (in shares) at May. 01, 2016			12,265,489
Net income		9,789
Unrealized gain on investments		100
Balance at Oct. 30, 2016		135,949
Balance at May. 01, 2016		128,812	$ 614	43,795	84,547	(144)
Balance (in shares) at May. 01, 2016			12,265,489
Net income		22,334			22,334
Stock-based compensation		3,358		3,358
Unrealized gain on investments		140				140
Excess tax benefit related to stock based compensation		657		657
Common stock issued in connection with vesting of performance based restricted stock units			$ 2	(2)
Common stock issued in connection with vesting of performance based restricted stock units (in shares)			49,192
Fully vested common stock award			4,800
Common stock issued in connection with exercise of stock options		588	$ 3	585
Common stock issued in connection with exercise of stock options (in shares)			68,000
Common stock surrendered for the cost of stock option exercises and withholding taxes payable		(979)	$ (1)	(978)
Common stock surrendered for the cost of stock option exercises and withholding taxes payable (in shares)			(30,850)
Dividends paid		(6,280)			(6,280)
Balance at Apr. 30, 2017	[1]	148,630	$ 618	47,415	100,601	(4)
Balance (in shares) at Apr. 30, 2017	[1]		12,356,631
Net income		8,959			8,959
Stock-based compensation		1,558		1,558
Unrealized gain on investments		64				64
Common stock issued in connection with vesting of performance based restricted stock units			$ 6	(6)
Common stock issued in connection with vesting of performance based restricted stock units (in shares)			118,845
Fully vested common stock award			4,800
Common stock issued in connection with vesting of time- based restricted stock unit (in shares)			1,200
Common stock issued in connection with exercise of stock options		5		5
Common stock issued in connection with exercise of stock options (in shares)			600
Common stock surrendered for the cost of stock option exercises and withholding taxes payable		(1,533)	$ (2)	(1,531)
Common stock surrendered for the cost of stock option exercises and withholding taxes payable (in shares)			(46,800)
Dividends paid		(4,603)			(4,603)
Balance at Oct. 29, 2017		$ 153,080	$ 622	$ 47,441	$ 104,957	$ 60
Balance (in shares) at Oct. 29, 2017			12,435,276
[1]	Derived from audited financial statements.

Basis of Presentation

Basis of Presentation	6 Months Ended
	Oct. 29, 2017
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited consolidated financial statements of Culp, Inc. and subsidiaries (the “company”) include all adjustments, which are, in the opinion of management, necessary for fair presentation of the results of operations and financial position. All of these adjustments are of a normal recurring nature. Results of operations for interim periods may not be indicative of future results. The unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements, which are included in the company’s annual report on Form 10-K filed with the Securities and Exchange Commission on July 14, 2017, for the fiscal year ended April 30, 2017. The company’s six months ended October 29, 2017, and October 30, 2016, represent 26 week periods, respectively.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Oct. 29, 2017
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies As of October 29, 2017, there were no changes in the nature of our significant accounting policies or the application of those policies from those reported in our annual report on Form 10-K for the year then ended April 30, 2017. Recently Adopted Accounting Pronouncements Measurement of Inventory In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”, which changed the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. ASU No. 2015-11 was effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2016. As a result, we adopted ASU No. 2015-11 in the first quarter of fiscal 2018 and the adoption of this guidance did not have a significant impact on our consolidated financial statements. Stock-Based Compensation In March 2016, the FASB issued ASU No. 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting". ASU No. 2016-09 was effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2016. Accordingly, we adopted this guidance during the first quarter of fiscal 2018. ASU No. 2016-09 aims to simplify several aspects of accounting and financial reporting for share-based payment transactions. One provision within this pronouncement requires that excess income tax benefits and deficiencies related to share-based payments be recognized within income tax expense as a discrete event in the period in which they occur, rather than within additional paid-in capital on our consolidated balance sheet on a prospective basis. The impact to our results of operations related to this provision through the second quarter of fiscal 2018 was a reduction to income tax expense of $556,000. The impact of this provision on our future results of operations will depend in part on the market prices for the shares of our common stock on the dates there are taxable events related to the share-based awards, and therefore, the impact is difficult to predict. In connection with another provision within ASU No. 2016-09, we have elected to account for forfeitures of share-based awards as an estimate of the number of awards that are expected to vest, which is consistent with our accounting policy prior to adoption. Also, we adopted the provisions of ASU No. 2016-09 related to changes on the Consolidated Statements of Cash Flows on a retrospective basis. As a result, we no longer classify excess income tax benefits as a financing activity, which increased net cash provided by operating activities and reduced net cash provided by financing activities by $167,000 for the six months ended October 30, 2016. Additionally, we no longer classify payments for employee taxes when common stock shares are withheld to satisfy the employer’s statutory income tax withholding obligation as an operating activity, which increased net cash provided by operating activities and reduced net cash provided by financing activities by $280,000 for the six months ended October 30, 2016. Recently Issued Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, which amends ASC Topic 606, Revenue from Contracts with Customers. Revenue from Contracts with Customers: Deferral of the Effective Date In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, There are no other new accounting pronouncements that are expected to have a significant impact on our consolidated financial statements.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Oct. 29, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	3. Stock-Based Compensation Equity Incentive Plan Description On September 16, 2015, our shareholders approved an equity incentive plan entitled the Culp, Inc. 2015 Equity Incentive Plan (the “2015 Plan”). The 2015 Plan updated and replaced our 2007 Equity Incentive Plan (the “2007 Plan”) as the vehicle for granting new equity based awards substantially similar to those authorized under the 2007 Plan. In general, the 2015 Plan authorizes the grant of stock options intended to qualify as incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, and other equity and cash related awards as determined by our Compensation Committee. An aggregate of 1,200,000 shares of common stock were authorized for issuance under the 2015 Plan, with certain sub-limits that would apply with respect to specific types of awards that may be issued as defined in the 2015 Plan. In connection with the approval of the 2015 Plan, no further awards will be granted under the 2007 Plan, but outstanding awards under the 2007 Plan will be settled in accordance with their terms. At October 29, 2017, there were 902,556 shares available for future equity based grants under our 2015 plan. Incentive Stock Option Awards We did not grant any incentive stock option awards through the through the second quarter of fiscal 2018. At October 29, 2017, options to purchase 15,000 shares of common stock were outstanding and exercisable, had a weighted average exercise price of $7.08 per share, and a weighted average contractual term of 0.6 years. At October 29, 2017, the aggregate intrinsic value for options outstanding and exercisable was $373,000. The aggregate intrinsic value for options exercised for the six months ending October 29, 2017 and October 30, 2016, was $14,000 and $43,000, respectively. At October 29, 2017, there were no unvested incentive stock option awards. Therefore, there was no unrecognized compensation cost related to incentive stock option awards at October 29, 2017. No compensation expense was recorded for incentive stock options for the six months ended October 29, 2017 and October 30, 2016, respectively. Performance Based Restricted Stock Units Executive Management On July 13, 2017, we granted performance-based restricted stock units to members of executive management (NEOs) which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit agreements. The number of shares of common stock that are earned based on the performance targets that have been achieved will be adjusted based on a market-based total shareholder return component as defined in the related restricted stock unit agreements. Compensation cost is measured based on the fair market value on the date of grant (July 13, 2017). The fair market value per share was determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock for the performance-based components. The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on the date of grant: Closing price of our common stock $ 32.50 Expected volatility of our common stock 31.0 % Expected volatility of peer companies 16.5 % Risk-free interest rate 1.56 % Dividend yield 1.66 % Correlation coefficient of peer companies 0.46 On July 14, 2016 and July 15, 2015, we granted performance-based restricted stock units to NEOs which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit agreements. These awards were measured based on the fair market value (closing price of our common stock) on the date of grant. No market-based total shareholder return component was included in these awards. Key Employees and a Non-Employee We granted performance-based restricted stock units which could earn up to a certain number of shares of common stock if certain performance targets are met over a three-fiscal year performance period as defined in the related restricted stock unit agreements. Our performance based restricted stock units granted to key employees were measured based on the fair market value (the closing price of our common stock) on the date of grant. Our performance based restricted stock units granted to a non-employee were measured based on the fair market value (the closing price of our common stock) at the earlier date of when the performance criteria are met or the end of the reporting period. No market-based total shareholder return component was included in these awards. (3) Restricted Stock Price Per Vesting Date of Grant Units Awarded Share Period July 13, 2017 (1) 78,195 $31.85 (4) 3 years July 13, 2017 (2) 44,000 $32.50 (5) 3 years July 14, 2016 (1) (2) 107,880 $28.00 (5) 3 years July 15, 2015 (1) (2) 107,554 $32.23 (5) 3 years (1) Performance-based restricted stock units awarded to NEOs. (2) Performance-based restricted stock units awarded to key employees. (3) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (4) Price per share represents the fair market value per share ($0.98 per $1 or a reduction of $0.65 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($32.50) for the performance-based components of the performance-based restricted stock units granted to our NEOs on July 13, 2017. (5) Price per share represents the closing price of our common stock on the date of grant. The following table summarizes information related to our grants of performance-based restricted stock units associated with a non-employee that are currently unvested: (1) Restricted Stock Price Per Vesting Date of Grant Units Awarded Share Period July 13, 2017 10,200 $31.95 (2) 3 years July 14, 2016 11,549 $31.95 (2) 3 years July 15, 2015 10,364 $31.95 (2) 3 years (1) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (2) The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on October 29, 2017, the end of our reporting period. The following table summarizes information related to our performance based restricted stock units that vested during the six month periods ending October 29, 2017 and October 30, 2016: (3) Common Stock Weighted Average Price Fiscal Year Shares Vested Fair Value Per Share Fiscal 2018 (1) 102,845 $1,820 $17.70 (4) Fiscal 2018 (2) 16,000 $520 $32.50 (5) Fiscal 2017 (1) 37,192 $637 $17.12 (4) Fiscal 2017 (2) 12,000 $345 $28.77 (5) (1) NEOs and key employees. (2) Non-employee (3) Dollar amounts are in thousands. (4) Price per share represents closing price of our common stock on the date of grant. (5) The respective grant vested during the first quarter of fiscal 2018 or 2017, respectively. Accordingly, the price per share represents the closing price of our common stock on the date the award vested. Overall We recorded compensation expense of $1.4 million and $1.5 million within selling, general, and administrative expense associated with our performance based restricted stock units for the six month periods ending October 29, 2017 and October 30, 2016, respectively. Compensation cost is recorded based on an assessment each reporting period of the probability that certain performance goals will be met during the vesting period. If performance goals are not probable of occurrence, no compensation cost will be recognized and any recognized compensation cost would be reversed. At October 29, 2017, the remaining unrecognized compensation cost related to the performance based restricted stock units was $4.3 million, which is expected to be recognized over a weighted average vesting period of 1.9 years. Common Stock Awards We granted a total of 4,800 shares of common stock to our outside directors on October 2, 2017, and October 3, 2016, respectively. These shares of common stock vested immediately and were valued based on the fair market value on the date of grant. The fair value of these awards were $33.20 and $29.80 per share, on October 2, 2017, and October 3, 2016, which represents the closing price of our common stock on the date of grant. We recorded $159,000 and $143,000 of compensation expense within selling, general, and administrative expense for these common stock awards for the six month periods ending October 29, 2017 and October 30, 2016, respectively. Time Vested Restricted Stock Units Fiscal 2018 Grant On July 13, 2017, an employee was granted 1,200 shares of time vested restricted stock units which vested over the requisite service period of 11 months. This award was measured at its fair market value, which was $32.50 per share, and represented the closing price of our common stock on the date of grant. Fiscal 2017 Grant On July 14, 2016, an employee was granted 1,200 shares of time vested restricted stock units which vested over the requisite service period of 11 months. This award was measured at its fair market value, which was $28 per share, and represented the closing price of our common stock on the date of grant. During the first quarter of fiscal 2018, 1,200 shares of common stock associated with this grant vested and had a weighted average fair value of $34,000 or $28 per share. Overall We recorded compensation expense of $17,000 and $11,000 within selling, general, and administrative expense associated with our time vested restricted stock unit awards for the six month periods ending October 29, 2017 and October 30, 2016, respectively. At October 29, 2017, the remaining unrecognized compensation cost related to unvested time vested restricted stock awards was $27,000, which is expected to be recognized over the next 7.5 months.

Accounts Receivable

Accounts Receivable	6 Months Ended
	Oct. 29, 2017
Receivables [Abstract]
Accounts Receivable	4. Accounts Receivable A summary of accounts receivable follows: (dollars in thousands October 29, 2017 October 30, 2016 April 30, 2017 Customers $ 25,593 $ 20,580 $ 26,211 Allowance for doubtful accounts (374 ) (420 ) (414 ) Reserve for returns and allowances and discounts (999 ) (1,121 ) (1,220 ) $ 24,220 $ 19,039 $ 24,577 A summary of the activity in the allowance for doubtful accounts follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Beginning balance $ (414 ) $ (1,088 ) Provision for bad debts 40 216 Net write-offs, net of recoveries - 452 Ending balance $ (374 ) $ (420 ) A summary of the activity in the allowance for returns and allowances and discounts accounts follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Beginning balance $ (1,220 ) $ (962 ) Provision for returns, allowances and discounts (1,330 ) (1,620 ) Credits issued 1,551 1,461 Ending balance $ (999 ) $ (1,121 )

Inventories

Inventories	6 Months Ended
	Oct. 29, 2017
Inventory Disclosure [Abstract]
Inventories	5. Inventories Inventories are carried at the lower of cost or market. Cost is determined using the FIFO (first-in, first-out) method. A summary of inventories follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Raw materials $ 6,617 $ 6,128 $ 6,456 Work-in-process 2,686 2,518 3,095 Finished goods 40,906 37,308 41,931 $ 50,209 $ 45,954 $ 51,482

Other Assets

Other Assets	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Other Assets	6. Other Assets A summary of other assets follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Cash surrender value – life insurance $ 376 $ 358 $ 376 Non-compete agreement, net 790 866 828 Customer relationships, net 638 689 664 Other 536 582 526 $ 2,340 $ 2,495 $ 2,394 Non-Compete Agreement We recorded our non-compete agreement at its fair value based on a discounted cash flow valuation model. Our non-compete agreement is amortized on a straight-line basis over the fifteen year life of the respective agreement. The gross carrying amount of our non-compete agreement was $2.0 million at October 29, 2017, October 30, 2016 and April 30, 2017, respectively. Accumulated amortization for our non-compete agreement was $1.2 million at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. Amortization expense for our non-compete agreement was $38,000 for the six month periods ending October 29, 2017 and October 30, 2016. The remaining amortization expense for the next five fiscal years and thereafter follows: FY 2018 - $37,000; FY 2019 - $75,000; FY 2020 - $75,000; FY 2021 - $75,000; FY 2022 - $75,000 and Thereafter - $453,000. The weighted average amortization period for our non-compete agreement is 10.5 years as of October 29, 2017. Customer Relationships We recorded our customer relationships at their fair value based on a multi-period excess earnings valuation model. Our customer relationships are amortized on a straight-line basis over its seventeen year useful life. The gross carrying amount of our customer relationships was $868,000 at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. Accumulated amortization for our customer relationships was $230,000, $179,000, and $204,000 at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. Amortization expense for our customer relationships was $26,000 for the six months ended October 29, 2017 and October 30, 2016. The remaining amortization expense for the next five fiscal years and thereafter follows: FY 2018 - $25,000; FY 2019 - $51,000; FY 2020 - $51,000; FY 2021 - $51,000; FY 2022 - $51,000; and Thereafter - $409,000. The weighted average amortization period for our customer relationships is 12.5 years as of October 29, 2017. Cash Surrender Value – Life Insurance At October 29, 2017, October 30, 2016, and April 30, 2017, we had one life insurance contract with a death benefit of $1.4 million. Our cash surrender value – life insurance balances totaling $376,000, $358,000 and $376,000 at October 29, 2017, October 30, 2016, and April 30, 2017, respectively, are collectible upon death of the respective insured.

Accrued Expenses

Accrued Expenses	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Accrued Expenses	7. Accrued Expenses A summary of accrued expenses follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Compensation, commissions and related benefits $ 5,399 $ 7,111 $ 10,188 Advertising rebates 650 734 468 Interest 18 5 51 Other accrued expenses 1,297 1,028 1,240 $ 7,364 $ 8,878 $ 11,947

Lines of Credit

Lines of Credit	6 Months Ended
	Oct. 29, 2017
Debt Disclosure [Abstract]
Lines of Credit	8. Lines of Credit Revolving Credit Agreement – United States Our Credit Agreement with Wells Fargo Bank, N.A. (“Wells Fargo”) provides a revolving loan commitment of $30 million. Interest was charged at a rate (applicable interest rate of 2.69%, 1.98%, and 2.45% at October 29, 2017, October 30, 2016, and April 30, 2017) as a variable spread over LIBOR based on our ratio of debt to EBITDA. The Credit Agreement contains certain financial and other covenants as defined in the agreement and is set to expire on August 15, 2018. The purposes of our revolving credit line is to support potential short term cash needs in different jurisdictions within our global operations, mitigate our risk associated with foreign currency exchange rate fluctuations, and ultimately repatriate earnings and profits from our foreign subsidiaries to the U.S. for various strategic purposes. Outstanding borrowings are secured by a pledge of 65% of the common stock of Culp International Holdings Ltd. (our subsidiary located in the Cayman Islands), as required by the Credit Agreement. There were no borrowings outstanding under the Credit Agreement at October 29, 2017, October 30, 2016, and April 30, 2017. At October 29, 2017, October 30, 2016, and April 30, 2017, there were $250,000 in outstanding letters of credit (all of which related to workers compensation) provided by the Credit Agreement. Effective August 1, 2016, we entered into a Third Amendment to our Credit Agreement that allows us to issue letters of credit not to exceed $7.5 million. On August 3, 2016, we issued a $5.0 million letter of credit ($3.75 million is currently outstanding in addition to the $250,000 letter of credit noted above) for the construction of a new building associated with our mattress fabrics segment (see Note 15 for further details). The $3.75 million outstanding letter of credit will be automatically reduced in increments of $1.25 million on November 1, 2017, February 1, 2018, and May 15, 2018, respectively. Revolving Credit Agreement – China We have an unsecured credit agreement associated with our operations in China that provides for a line of credit of up to 40 million Chinese Yuan Renminbi (approximately $6.0 million USD at October 29, 2017), that expires February 15, 2018. This agreement has an interest rate determined by the Chinese government and there were no borrowings outstanding as of October 29, 2017, October 30, 2016, and April 30, 2017. Overall Our loan agreements require, among other things, that we maintain compliance with certain financial covenants. At October 29, 2017, the company was in compliance with these financial covenants.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Oct. 29, 2017
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	9. Fair Value of Financial Instruments ASC Topic 820 establishes a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and the company’s assumptions (unobservable inputs). Determining where an asset or liability falls within that hierarchy depends on the lowest level input that is significant to the fair value measurement as a whole. An adjustment to the pricing method used within either level 1 or level 2 inputs could generate a fair value measurement that effectively falls in a lower level in the hierarchy. The hierarchy consists of three broad levels as follows: Level 1 – Quoted market prices in active markets for identical assets or liabilities; Level 2 – Inputs other than level 1 inputs that are either directly or indirectly observable, and Level 3 – Unobservable inputs developed using the company’s estimates and assumptions, which reflect those that market participants would use. Recurring Basis The following table presents information about assets measured at fair value on a recurring basis: Fair value measurements at October 29, 2017 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Corporate Bonds $ - $ 30,773 $ - $ 30,773 Premier Money Market Fund 6,153 N/A N/A 6,153 Low Duration Bond Fund 1,087 N/A N/A 1,087 Intermediate Term Bond Fund 765 N/A N/A 765 Strategic Income Fund 626 N/A N/A 626 Large Blend Fund 393 N/A N/A 393 Growth Allocation Fund 153 N/A N/A 153 Moderate Allocation Fund 107 N/A N/A 107 Other 115 N/A N/A 115 Fair value measurements at October 30, 2016 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: Cash and Cash Equivalents $ 23,940 N/A N/A $ 23,940 U.S. Corporate Bonds - 7,110 N/A 7,110 Premier Money Market Fund 4,421 N/A N/A 4,421 Low Duration Bond Fund 1,075 N/A N/A 1,075 Intermediate Term Bond Fund 750 N/A N/A 750 Strategic Income Fund 605 N/A N/A 605 Large Blend Fund 319 N/A N/A 319 Growth Allocation Fund 102 N/A N/A 102 Other 152 N/A N/A 152 Fair value measurements at April 30, 2017 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Corporate Bonds $ - $ 30,831 $ - $ 30,831 Premier Money Market Fund 4,811 N/A N/A 4,811 Low Duration Bond Fund 1,081 N/A N/A 1,081 Intermediate Term Bond Fund 751 N/A N/A 751 Strategic Income Fund 611 N/A N/A 611 Large Blend Fund 365 N/A N/A 365 Growth Allocation Fund 126 N/A N/A 126 Moderate Allocation Fund 88 N/A N/A 88 Other 76 N/A N/A 76 Our U.S. corporate bonds were classified as level 2 as they are traded over the counter within a broker network and not on an active market. The fair value of our U.S. corporate bonds is determined based on a published source that provides an average bid price. The average bid price is based on various broker prices that are determined based on market conditions, interest rates, and the rating of the respective U.S. corporate bond. The determination of where an asset or liability falls in the hierarchy requires significant judgment. We evaluate our hierarchy disclosures each quarter based on various factors and it is possible that an asset or liability may be classified differently from quarter to quarter. However, we expect that changes in classifications between different levels will be rare. Short-Term Investments – Available for Sale At October 29, 2017, October 30, 2016, and April 30, 2017, our short-term investments classified as available for sale totaled $2.5 million, $2.4 million, and $2.4 million, respectively, and consisted of short-term bond funds. Since these short-term bond funds are classified as available for sale, these investments are recorded at their fair market value and their unrealized gains or losses are included in other comprehensive income (loss). Our short-term bond investments had an accumulated unrealized loss totaling $36,000, $45,000, and $47,000 at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. At October 29, 2017, October 30, 2016, and April 30, 2017, the fair value of our short-term bond funds approximated its cost basis. Short-Term and Long-Term Investments - Held-To-Maturity During the second quarter of fiscal 2017, management decided to invest approximately $31.0 million in investment grade U.S. Corporate bonds with maturities that ranged from 2 to 2.5 years. The purpose of this investment was to earn a higher rate of return on our excess cash located in the Cayman Islands. These investments are classified as held-to-maturity as we have the positive intent and ability to hold these investments until maturity. Our held-to-maturity investments will be recorded as either current or noncurrent on our Consolidated Balance Sheets, based on contractual maturity date as of a respective reporting period and stated at amortized cost. At October 29, 2017 and April 30, 2017, our held-to-maturity investments totaled $30.9 million and consisted of U.S. Corporate bonds. At October 30, 2016, our held-to-maturity investments totaled $31.0 million and consisted of invested cash and cash equivalents of $23.9 million and U.S. Corporate bonds of $7.1 million. The $23.9 million in invested cash and cash equivalents were used to purchase U.S. Corporate bonds during our third quarter of fiscal 2017. The fair value of our held-to-maturity investments at October 29, 2017, October 30, 2016, and April 30, 2017 totaled $30.8 million, $31.0 million, and $30.8 million, respectively. Long-Term Investments - Rabbi Trust We have a Rabbi Trust to set aside funds for participants of our deferred compensation plan (the “Plan”) and enable the participants to credit their contributions to various investment options of the Plan. The investments associated with the Rabbi Trust consist of a money market fund and various mutual funds that are classified as available for sale. These long-term investments are recorded at their fair values of $6.9 million, $5.0 million, and $5.5 million at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. Our long-term investments had an accumulated unrealized gain of $96,000, $1,000 and $43,000 at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. The fair value of our long-term investments associated with our Rabbi Trust approximates its cost basis. Other The carrying amount of our cash and cash equivalents, accounts receivable, other current assets, accounts payable, accrued expenses, and line of credit approximates fair value because of the short maturity of these financial instruments.

Cash Flow Information

Cash Flow Information	6 Months Ended
	Oct. 29, 2017
Supplemental Cash Flow Elements [Abstract]
Cash Flow Information	10. Cash Flow Information Interest and income taxes paid are as follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Interest $ 146 $ 45 Income taxes 2,599 3,238 Interest costs charged to operations were $137,000 and $45,000 for the six months ended October 29, 2017 and October 30, 2016, respectively. Interest costs of $100,000 and $45,000 for the construction of qualifying fixed assets were capitalized and will be amortized over the related assets’ useful lives for the six months ended October 29, 2017 and October 30, 2016, respectively.

Net Income Per Share

Net Income Per Share	6 Months Ended
	Oct. 29, 2017
Earnings Per Share [Abstract]
Net Income Per Share	11. Net Income Per Share Basic net income per share is computed using the weighted-average number of shares outstanding during the period. Diluted net income per share uses the weighted-average number of shares outstanding during the period plus the dilutive effect of stock-based compensation calculated using the treasury stock method. Weighted average shares used in the computation of basic and diluted net income per share follows: Three months ended (amounts in thousands) October 29, 2017 October 30, 2016 Weighted average common shares outstanding, basic 12,440 12,308 Dilutive effect of stock-based compensation 140 199 Weighted average common shares outstanding, diluted 12,580 12,507 All options to purchase shares of common stock were included in the computation of diluted net income for the three months ended October 29, 2017 and October 30, 2016, as the exercise price of the options was less than the average market price of the common shares. Six months ended (amounts in thousands) October 29, 2017 October 30, 2016 Weighted average common shares outstanding, basic 12,420 12,297 Dilutive effect of stock-based compensation 193 198 Weighted average common shares outstanding, diluted 12,613 12,495 All options to purchase shares of common stock were included in the computation of diluted net income for the six months ended October 29, 2017 and October 30, 2016, as the exercise price of the options was less than the average market price of the common shares.

Segment Information

Segment Information	6 Months Ended
	Oct. 29, 2017
Segment Reporting [Abstract]
Segment Information	12. Segment Information Our operations are classified into two business segments: mattress fabrics and upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment manufactures, sources, develops, and sells fabrics primarily to residential and commercial furniture manufacturers. We evaluate the operating performance of our segments based upon income from operations before certain unallocated corporate expenses and other non-recurring items. Cost of sales in both segments include costs to manufacture, develop, or source our products, including costs such as raw material and finished goods purchases, direct and indirect labor, overhead and incoming freight charges. Unallocated corporate expenses primarily represent compensation and benefits for certain executive officers, all costs related to being a public company, and other miscellaneous expenses. Segment assets include assets used in the operations of each segment and primarily consist of accounts receivable, inventories, and property, plant and equipment. The mattress fabrics segment also includes in segment assets, goodwill, investment in an unconsolidated joint venture, a non-compete agreement, and customer relationships associated with an acquisition. Financial information for the company’s operating segments follows: Three months ended October 29, 2017 October 30, 2016 Net sales: Mattress Fabrics $ 48,601 $ 45,527 Upholstery Fabrics 32,097 29,816 $ 80,698 $ 75,343 Gross profit: Mattress Fabrics $ 9,730 $ 10,756 Upholstery Fabrics 6,074 6,145 $ 15,804 $ 16,901 Mattress Fabrics $ 3,168 $ 3,296 Upholstery Fabrics 3,700 3,652 Total segment selling, general, and administrative expenses 6,868 6,948 Unallocated corporate expenses 2,547 2,654 $ 9,415 $ 9,602 Income from operations: Mattress Fabrics $ 6,562 $ 7,460 Upholstery Fabrics 2,374 2,493 Total segment income from operations 8,936 9,953 Unallocated corporate expenses (2,547 ) (2,654 ) Total income from operations 6,389 7,299 Interest expense (37 ) - Interest income 128 15 Other expense (321 ) (155 ) Income before income taxes $ 6,159 $ 7,159 Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Net sales: Mattress Fabrics $ 97,030 $ 96,057 Upholstery Fabrics 63,200 59,969 $ 160,230 $ 156,026 Gross profit: Mattress Fabrics $ 19,495 $ 22,657 Upholstery Fabrics 12,773 12,664 $ 32,268 $ 35,321 Selling, general, and administrative expenses: Mattress Fabrics $ 6,559 $ 6,795 Upholstery Fabrics 7,511 7,185 Total segment selling, general, and administrative expenses 14,070 13,980 Unallocated corporate expenses 4,846 5,368 $ 18,916 $ 19,348 Income from operations: Mattress Fabrics $ 12,936 $ 15,862 Upholstery Fabrics 5,262 5,479 Total segment income from operations 18,198 21,341 Unallocated corporate expenses (4,846 ) (5,368 ) Total income from operations 13,352 15,973 Interest expense (37) - Interest income 259 40 Other expense (674 ) (307 ) Income before income taxes $ 12,900 $ 15,706 Balance sheet information for the company’s operating segments follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Segment assets: Mattress Fabrics Current assets (1) $ 42,728 $ 38,062 $ 47,038 Non-compete agreement 790 866 828 Customer relationships 638 689 664 Investment in unconsolidated joint venture 1,522 - 1,106 Goodwill 11,462 11,462 11,462 Property, plant and equipment (2) 49,965 43,228 48,916 Total mattress fabrics assets 107,105 94,307 110,014 Upholstery Fabrics Current assets (1) 31,701 26,931 29,021 Property, plant and equipment (3) 2,063 1,480 1,879 Total upholstery fabrics assets 33,764 28,411 30,900 Total segment assets 140,869 122,718 140,914 Non-segment assets: Cash and cash equivalents 15,739 13,910 20,795 Short-term investments (Available for Sale) 2,478 2,430 2,443 Short-term investments (Held-to-Maturity) 4,015 - - Deferred income taxes 491 581 419 Other current assets 2,263 1,675 2,894 Property, plant and equipment (4) 502 829 856 Long-term investments (Held-to-Maturity) 26,853 31,050 30,945 Long-term investments (Rabbi Trust) 6,921 4,994 5,466 Other assets 912 940 902 Total assets $ 201,043 $ 179,127 $ 205,634 Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Capital expenditures (5): Mattress Fabrics $ 4,364 $ 8,857 Upholstery Fabrics 203 165 Unallocated Corporate 30 62 Total capital expenditures $ 4,597 $ 9,084 Depreciation expense: Mattress Fabrics $ 3,310 $ 3,101 Upholstery Fabrics 403 410 Total depreciation expense $ 3,713 $ 3,511 (1) Current assets represent accounts receivable and inventory for the respective segment. (2) The $50.0 million at October 29, 2017, represents property, plant, and equipment of $35.8 million and $14.2 million located in the U.S. and Canada, respectively. The $43.2 million at October 30, 2016, represents property, plant, and equipment of $28.5 million and $14.7 million located in the U.S. and Canada, respectively. The $48.9 million at April 30, 2017, represents property, plant, and equipment of $34.0 million and $14.9 million located in the U.S. and Canada, respectively. (3) The $2.1 million at October 29, 2017, represents property, plant, and equipment of $1.4 million and $722 located in the U.S. and China, respectively. The $1.5 million at October 30, 2016, represents property, plant, and equipment of $890 and $590 located in the U.S. and China, respectively. The $1.9 million at April 30, 2017, represents property, plant, and equipment of $1.2 million and $655 located in the U.S. and China, respectively. (4) The $502, $829, and $856 at October 29, 2017, October 30, 2016 and April 30, 2017, respectively, represent property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by both the mattress and upholstery fabric segments. Property, plant, and equipment associated with corporate are located in the U.S. (5) Capital expenditure amounts are stated on the accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis.

Income Taxes

Income Taxes	6 Months Ended
	Oct. 29, 2017
Income Tax Disclosure [Abstract]
Income Taxes	13. Income Taxes Effective Income Tax Rate We recorded income tax expense of $3.7 million, or 29.1% of income before income taxes, for the six month period ended October 29, 2017, compared to income tax expense of $5.9 million, or 37.7% of income before income taxes, for the six month period ended October 30, 2016. Our effective income tax rates for the six month periods ended October 29, 2017, and October 30, 2016, were based upon the estimated effective income tax rate applicable for the full year after giving effect to any significant items related specifically to interim periods. The effective income tax rate can be affected over the fiscal year by the mix and timing of actual earnings from our U.S. operations and foreign sources versus annual projections and changes in foreign currency exchange rates in relation to the U.S. dollar. The following schedule summarizes the factors that contribute to the difference between income tax expense at the federal income tax rate and the effective income tax rate reflected in the consolidated financial statements: 2018 2017 Federal income tax rate 34.0 % 34.0 % Excess income tax benefits related to stock-based compensation (4.3 ) - Tax effects of Chinese foreign exchange (losses) gains (1.5 ) 1.6 U.S. state income tax expense 0.4 0.6 Other 0.5 1.5 29.1 % 37.7 % Deferred Income Taxes Valuation Allowance In accordance with ASC Topic 740, we evaluate our deferred income taxes to determine if a valuation allowance is required. ASC Topic 740 requires that companies assess whether a valuation allowance should be established based on the consideration of all available evidence using a “more-likely-than-not” standard, with significant weight being given to evidence that can be objectively verified. Since the company operates in multiple jurisdictions, we assess the need for a valuation allowance on a jurisdiction-by-jurisdiction basis, taking into account the effects of local tax law. Based on our assessment at October 29, 2017, we recorded a partial valuation allowance of $632,000, of which $554,000 pertained to certain U.S. No valuation allowance was recorded against our net deferred income tax assets associated with our operations located in China and Canada at October 29, 2017, October 30, 2016, and April 30, 2017, respectively. The recorded valuation allowance of $632,000 at October 29, 2017, has no effect on our operations, loan covenant compliance, or the possible realization of certain U.S. state net operating loss carryforwards and credits and our loss carryforwards associated with our Culp Europe operation located in Poland. If it is determined that it is more-likely-than-not that we will realize any of these deferred income tax assets, an income tax benefit will be recognized at that time. Undistributed Earnings In accordance with ASC Topic 740, we assess whether the undistributed earnings from our foreign subsidiaries will be reinvested indefinitely or eventually distributed to our U.S. parent company. ASC Topic 740 requires that a deferred tax liability should be recorded for undistributed earnings from foreign subsidiaries that will not be reinvested indefinitely. Based on our assessment as of October 29, 2017, it is our intention not to permanently invest our undistributed earnings from our foreign subsidiaries, with the exception of $1.8 million that has been reinvested indefinitely since the fourth quarter of fiscal 2017 in our unconsolidated joint venture located in Haiti. Also, we assess the recognition of U.S. foreign income tax credits associated with foreign withholding and income tax payments and whether it is more-likely-than-not that our foreign income tax credits will not be realized. If it is determined that any foreign income tax credits need to be recognized or it is more-likely-than-not our foreign income tax credits will not be realized, an adjustment to our provision for income taxes will be recognized at that time. At October 29, 2017, we had accumulated earnings and profits from our foreign subsidiaries totaling $145.3 million. At the same date, the deferred tax liability associated with our undistributed earnings from our foreign subsidiaries totaled $322,000, which included U.S. income and foreign withholding taxes totaling $42.4 million, offset by U.S. foreign income tax credits of $42.1 million. At October 30, 2016, we had accumulated earnings and profits from our foreign subsidiaries totaling $138.9 million. At the same date, the deferred tax liability associated with our undistributed earnings from our foreign subsidiaries totaled $657,000, which included U.S. income and foreign withholding taxes totaling $41.4 million, offset by U.S. foreign income tax credits of $40.7 million. At April 30, 2017, we had accumulated earnings and profits from our foreign subsidiaries totaling $146.9 million. At the same date, the deferred tax liability associated with our undistributed earnings from our foreign subsidiaries totaled $497,000, which included U.S. income and foreign withholding taxes totaling $44.0 million, offset by U.S. foreign income tax credits of $43.5 million. Overall At October 29, 2017, our non-current deferred tax asset of $491,000 pertains to our operations located in China. At October 30, 2016, our non-current deferred tax asset of $581,000 represented $109,000 and $472,000 from our operations located in the U.S. and China, respectively. At April 30, 2017, our non-current deferred tax asset of $419,000 pertained to our operations located in China. At October 29, 2017, our non-current deferred tax liability of $4.6 million represents $2.5 million and $2.1 million from our operations located in the U.S. and Canada, respectively. Our non-current deferred tax liability balance of $1.7 million at October 30, 2016 pertained to our operations located in Canada. At April 30, 2017, our non-current deferred tax liability of $3.6 million represented $2.1 million and $1.5 million from our operations located in Canada and the U.S., respectively. Uncertainty In Income Taxes At October 29, 2017, we had a $12.6 million total gross unrecognized income tax benefit, of which $12.1 million and $487,000 were classified as non-current deferred income taxes and income taxes payable – long-term, respectively, in the accompanying consolidated balance sheets. At October 30, 2016, we had a $15.1 million total gross unrecognized income tax benefit, of which $11.4 million and $3.7 million were classified as non-current deferred income taxes and income taxes payable – long-term, respectively, in the accompanying consolidated balance sheets. At April 30, 2017, we had $12.2 million of total gross unrecognized income tax benefit, of which $11.8 million and $467,000 were classified as non-current deferred income taxes and income taxes payable – long-term, respectively, in the accompanying consolidated balance sheets. At October 29, 2017, our $12.6 million total gross unrecognized income tax benefit included $487,000 that, if recognized, would favorably affect the income tax rate in future periods. At October 30, 2016, our $15.1 million total gross unrecognized income tax benefit, included $3.7 million that, if recognized, would favorably affect the income tax rate in future periods. At April 30, 2017, our $12.2 million total gross unrecognized income tax benefit included $467,000 that, if recognized, would favorably affect the income tax rate in future periods. Our gross unrecognized income tax benefit of $12.6 million at October 29, 2017, relates to tax positions for which significant change is reasonably possible within the next year (see below disclosure of ongoing income tax exams). This amount primarily relates to double taxation under applicable income tax treaties with foreign tax jurisdictions. United States federal and state income tax returns filed by us remain subject to examination for income tax years 2005 and subsequent due to loss carryforwards. Canadian federal and provincial (Quebec) returns filed by us remain subject to examination for income tax years 2013 and subsequent. Income tax returns associated with our operations located in China are subject to examination for income tax year 2012 and subsequent. The Internal Revenue Service is examining our U.S. Federal income tax returns for fiscal years 2014 through 2016. As a result of this examination, the IRS proposed an adjustment approximating $12.5 million of income taxes that relates to our transfer pricing with certain foreign subsidiaries. Management does not agree with the IRS' proposed adjustment and intends to vigorously defend its position. Currently, the ultimate outcome of this proposed adjustment and any potential cash settlement cannot be determined as it is dependent upon potential legal and competent authority proceedings, interpretation of income tax law, and utilization of available loss carryforwards and certain income tax credits associated with the fiscal years under exam. We believe our unrecognized income tax benefit balance of $12.6 million has adequately provided for our uncertain income tax positions for all open income tax years and jurisdictions. Currently, we expect this examination to be completed during fiscal 2019. During the third quarter of fiscal 2017, Revenue Quebec commenced an examination of our Canadian provincial (Quebec) income tax returns for fiscal years 2013 through 2015, and no adjustments have been proposed at this time. We currently expect this examination to be completed during fiscal 2018. In accordance with ASC Topic 740, an unrecognized income tax benefit for an uncertain income tax position can be recognized in the first interim period if the more-likely-than-not recognition threshold is met by the reporting period, or is effectively settled through examination, negotiation, or litigation, or the statue of limitations for the relevant taxing authority to examine and challenge the tax position has expired. If it is determined that any of the above conditions occur regarding our uncertain income tax positions, an adjustment to our unrecognized income tax benefit will be recorded at that time.

Statutory Reserves

Statutory Reserves	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Statutory Reserves	14. Statutory Reserves Our subsidiaries located in China are required to transfer 10% of their net income, as determined in accordance with the People’s Republic of China (PRC) accounting rules and regulations, to a statutory surplus reserve fund until such reserve balance reaches 50% of the company’s registered capital. The transfer to this reserve must be made before distributions of any dividend to shareholders. As of October 29, 2017, the company’s statutory surplus reserve was $4.4 million, representing 10% of accumulated earnings and profits determined in accordance with PRC accounting rules and regulations. The surplus reserve fund is non-distributable other than during liquidation and can be used to fund previous years’ losses, if any, and may be utilized for business expansion or converted into share capital by issuing new shares to existing shareholders in proportion to their shareholding or by increasing the par value of the shares currently held by them provided that the remaining reserve balance after such issue is not less than 25% of the registered capital. Our subsidiaries located in China can transfer funds to the parent company with the exception of the statutory surplus reserve of $4.4 million to assist with debt repayment, capital expenditures, and other expenses of the company’s business.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Oct. 29, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	15. Commitments and Contingencies Litigation The company is involved in legal proceedings and claims which have arisen in the ordinary course of business. Management has determined that it is not reasonably possible that these actions, when ultimately concluded and settled, will have a material adverse effect upon the financial position, results of operations, or cash flows of the company. Accounts Payable – Capital Expenditures At October 29, 2017, October 30, 2016, and April 30, 2017, we had total amounts due regarding capital expenditures totaling $3.2 million, $3.0, and $6.1 million, respectively, of which $2.7 million, $1.5 million, and $5.1 million was financed and pertained to completed work for the construction of a new building (see below). Of the total $2.7 million due at October 29, 2017, $1.3 million is required to be paid during the remainder of fiscal 2018, with a remaining amount of $1.4 million due in fiscal 2019 (May 2018). Purchase Commitments – Capital Expenditures At October 29, 2017, we had open purchase commitments to acquire a building and equipment for our mattress fabrics segment totaling $3.8 million. The $3.8 million includes $2.7 million (all of which represents completed work) associated with the construction of a new building discussed below. Effective May 16, 2016, we entered into an agreement with a contractor to construct a new building located in North Carolina to expand our distribution capabilities and office space at a cost of $11.3 million. This agreement required an installment payment of $1.9 million in April 2016 with additional installment payments to be made in the following fiscal years: Fiscal 2017- $4.3 million; Fiscal 2018- $3.7 million; and Fiscal 2019 - $1.4 million. Interest is charged on the required outstanding installment payments for services that were previously rendered at a rate of $2.25% plus the current 30 day LIBOR rate. Also, we were required to issue a letter of a credit totaling $5.0 million with the contractor’s bank being the beneficiary. In addition to the interest charged on the outstanding installment payments noted above, there is a 0.1% unused fee calculated on the balance of the $5.0 million letter of credit less the amount outstanding per month (see Note 8 for further details). This new building was placed into service in July 2017.

Investment in Unconsolidated Jo

Investment in Unconsolidated Joint Venture	6 Months Ended
	Oct. 29, 2017
Equity Method Investments and Joint Ventures [Abstract]
Investment in Unconsolidated Joint Venture	16. Investment in Unconsolidated Joint Venture Effective January 1, 2017, Culp International Holdings, Ltd. (Culp), a wholly-owned subsidiary of Culp, Inc., entered into a joint venture agreement, pursuant to which Culp owns fifty percent of CLASS International Holdings, Ltd (CLIH). CLIH produces cut and sewn mattress covers, and its operations are located in a modern industrial park in northeastern Haiti, which borders the Dominican Republic. CLIH commenced production during the second quarter of fiscal 2018 (October 2017) and is expected to complement our existing U.S. mattress fabric operations with a mirrored platform that will enhance our ability to meet customer demand while adding a lower cost operation to our platform. During the six month period ended October 29, 2017, CLIH incurred a $386,000 net loss that primarily pertained to start-up operating expenses. Our equity interest in this net loss was $193,000, which represents the company’s fifty percent ownership in CLIH. The following table summarizes information on assets, liabilities and members’ equity of our equity method investment in CLIH: October 29, April 30, (dollars in thousands) 2017 2017 Total assets $ 3,180 $ 2,258 Total liabilities $ 136 $ 46 Total members’ equity $ 3,044 $ 2,212 At October 29, 2017 and April 30, 2017, our investment in CLIH totaled $1.5 million and $1.1 million, respectively, which represents the company’s fifty percent ownership interest in CLIH.

Common Stock Repurchase Program

Common Stock Repurchase Program	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Common Stock Repurchase Program	17. Common Stock Repurchase Program On June 15, 2016, we announced that our board of directors approved an authorization for us to acquire up to $5.0 million of our common stock. Under the common stock repurchase program, shares may be purchased from time to time in open market transactions, block trades, through plans established under the Securities Exchange Act Rule 10b5-1, or otherwise. The amount of shares purchased and the timing of such purchases will be based on working capital requirements, market and general business conditions, and other factors, including alternative investment opportunities. During the six months ended October 29, 2017, and October 30, 2016, we did not purchase any shares of our common stock. At October 29, 2017, we had $5.0 million available for repurchases of our common stock.

Dividend Program

Dividend Program	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Dividend Program	18. Dividend Program On November 30, 2017, we announced that our board of directors approved a 12.5% increase in our quarterly cash dividend from $0.08 per share to $0.09 per share. This payment will be made on January 16, 2018, to shareholders of record as of January 2, 2018. During the first half of fiscal 2018, dividend payments totaled $4.6 million, of which $2.6 million represented a special cash dividend payment of $0.21 per share, and $2.0 million represented quarterly dividend payments of $0.08 per share. During the first half of fiscal 2017, dividend payments totaled $4.3 million, of which $2.5 million represented a special cash dividend payment of $0.21 per share, and $1.8 million represented quarterly dividend payments of $0.07 per share. Future dividend payments are subject to board approval and may be adjusted at the board’s discretion as business needs or market conditions change.

Significant Accounting Polici26

Significant Accounting Policies (Policies)	6 Months Ended
	Oct. 29, 2017
Accounting Policies [Abstract]
Recently Adopted and Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements Measurement of Inventory In July 2015, the FASB issued ASU No. 2015-11, “Simplifying the Measurement of Inventory”, which changed the measurement principle for inventory from the lower of cost or market to lower of cost and net realizable value. ASU No. 2015-11 was effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2016. As a result, we adopted ASU No. 2015-11 in the first quarter of fiscal 2018 and the adoption of this guidance did not have a significant impact on our consolidated financial statements. Stock-Based Compensation In March 2016, the FASB issued ASU No. 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting". ASU No. 2016-09 was effective for fiscal years and interim periods within those fiscal years, beginning after December 15, 2016. Accordingly, we adopted this guidance during the first quarter of fiscal 2018. ASU No. 2016-09 aims to simplify several aspects of accounting and financial reporting for share-based payment transactions. One provision within this pronouncement requires that excess income tax benefits and deficiencies related to share-based payments be recognized within income tax expense as a discrete event in the period in which they occur, rather than within additional paid-in capital on our consolidated balance sheet on a prospective basis. The impact to our results of operations related to this provision through the second quarter of fiscal 2018 was a reduction to income tax expense of $556,000. The impact of this provision on our future results of operations will depend in part on the market prices for the shares of our common stock on the dates there are taxable events related to the share-based awards, and therefore, the impact is difficult to predict. In connection with another provision within ASU No. 2016-09, we have elected to account for forfeitures of share-based awards as an estimate of the number of awards that are expected to vest, which is consistent with our accounting policy prior to adoption. Also, we adopted the provisions of ASU No. 2016-09 related to changes on the Consolidated Statements of Cash Flows on a retrospective basis. As a result, we no longer classify excess income tax benefits as a financing activity, which increased net cash provided by operating activities and reduced net cash provided by financing activities by $167,000 for the six months ended October 30, 2016. Additionally, we no longer classify payments for employee taxes when common stock shares are withheld to satisfy the employer’s statutory income tax withholding obligation as an operating activity, which increased net cash provided by operating activities and reduced net cash provided by financing activities by $280,000 for the six months ended October 30, 2016. Recently Issued Accounting Pronouncements In May 2014, the FASB issued ASU No. 2014-09, which amends ASC Topic 606, Revenue from Contracts with Customers. Revenue from Contracts with Customers: Deferral of the Effective Date In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, There are no other new accounting pronouncements that are expected to have a significant impact on our consolidated financial statements.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Oct. 29, 2017
Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units	The following table provides assumptions used to determine the fair market value of the market-based total shareholder return component using the Monte Carlo simulation model on the date of grant: Closing price of our common stock $ 32.50 Expected volatility of our common stock 31.0 % Expected volatility of peer companies 16.5 % Risk-free interest rate 1.56 % Dividend yield 1.66 % Correlation coefficient of peer companies 0.46
Summary of Vested Performance Based Restricted Stock Units	The following table summarizes information related to our performance based restricted stock units that vested during the six month periods ending October 29, 2017 and October 30, 2016: (3) Common Stock Weighted Average Price Fiscal Year Shares Vested Fair Value Per Share Fiscal 2018 (1) 102,845 $1,820 $17.70 (4) Fiscal 2018 (2) 16,000 $520 $32.50 (5) Fiscal 2017 (1) 37,192 $637 $17.12 (4) Fiscal 2017 (2) 12,000 $345 $28.77 (5) (1) NEOs and key employees. (2) Non-employee (3) Dollar amounts are in thousands. (4) Price per share represents closing price of our common stock on the date of grant. (5) The respective grant vested during the first quarter of fiscal 2018 or 2017, respectively. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.
NEOs and Key Employees [Member]
Summary of Grants of Performance Based Restricted Stock Units	The following table summarizes information related to our grants of performance based restricted stock units associated with NEOs and key employees that are currently unvested: (3) Restricted Stock Price Per Vesting Date of Grant Units Awarded Share Period July 13, 2017 (1) 78,195 $31.85 (4) 3 years July 13, 2017 (2) 44,000 $32.50 (5) 3 years July 14, 2016 (1) (2) 107,880 $28.00 (5) 3 years July 15, 2015 (1) (2) 107,554 $32.23 (5) 3 years (1) Performance-based restricted stock units awarded to NEOs. (2) Performance-based restricted stock units awarded to key employees. (3) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (4) Price per share represents the fair market value per share ($0.98 per $1 or a reduction of $0.65 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($32.50) for the performance-based components of the performance-based restricted stock units granted to our NEOs on July 13, 2017. (5) Price per share represents the closing price of our common stock on the date of grant.
Non-employee [Member]
Summary of Grants of Performance Based Restricted Stock Units	The following table summarizes information related to our grants of performance-based restricted stock units associated with a non-employee that are currently unvested: (1) Restricted Stock Price Per Vesting Date of Grant Units Awarded Share Period July 13, 2017 10,200 $31.95 (2) 3 years July 14, 2016 11,549 $31.95 (2) 3 years July 15, 2015 10,364 $31.95 (2) 3 years (1) Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements. (2) The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on October 29, 2017, the end of our reporting period.

Accounts Receivable (Tables)

Accounts Receivable (Tables)	6 Months Ended
	Oct. 29, 2017
Receivables [Abstract]
Summary of Accounts Receivable	A summary of accounts receivable follows: (dollars in thousands October 29, 2017 October 30, 2016 April 30, 2017 Customers $ 25,593 $ 20,580 $ 26,211 Allowance for doubtful accounts (374 ) (420 ) (414 ) Reserve for returns and allowances and discounts (999 ) (1,121 ) (1,220 ) $ 24,220 $ 19,039 $ 24,577
Summary of the Activity in the Allowance for Doubtful Accounts	A summary of the activity in the allowance for doubtful accounts follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Beginning balance $ (414 ) $ (1,088 ) Provision for bad debts 40 216 Net write-offs, net of recoveries - 452 Ending balance $ (374 ) $ (420 )
Summary of the Activity in the Allowance for Returns and Allowances and Discounts	A summary of the activity in the allowance for returns and allowances and discounts accounts follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Beginning balance $ (1,220 ) $ (962 ) Provision for returns, allowances and discounts (1,330 ) (1,620 ) Credits issued 1,551 1,461 Ending balance $ (999 ) $ (1,121 )

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Oct. 29, 2017
Inventory Disclosure [Abstract]
Summary of Inventories	A summary of inventories follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Raw materials $ 6,617 $ 6,128 $ 6,456 Work-in-process 2,686 2,518 3,095 Finished goods 40,906 37,308 41,931 $ 50,209 $ 45,954 $ 51,482

Other Assets (Tables)

Other Assets (Tables)	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Summary of Other Assets	A summary of other assets follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Cash surrender value – life insurance $ 376 $ 358 $ 376 Non-compete agreement, net 790 866 828 Customer relationships, net 638 689 664 Other 536 582 526 $ 2,340 $ 2,495 $ 2,394

Accrued Expenses (Tables)

Accrued Expenses (Tables)	6 Months Ended
	Oct. 29, 2017
Text Block [Abstract]
Summary of Accrued Expenses	A summary of accrued expenses follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Compensation, commissions and related benefits $ 5,399 $ 7,111 $ 10,188 Advertising rebates 650 734 468 Interest 18 5 51 Other accrued expenses 1,297 1,028 1,240 $ 7,364 $ 8,878 $ 11,947

Fair Value of Financial Instr32

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Oct. 29, 2017
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following table presents information about assets measured at fair value on a recurring basis: Fair value measurements at October 29, 2017 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Corporate Bonds $ - $ 30,773 $ - $ 30,773 Premier Money Market Fund 6,153 N/A N/A 6,153 Low Duration Bond Fund 1,087 N/A N/A 1,087 Intermediate Term Bond Fund 765 N/A N/A 765 Strategic Income Fund 626 N/A N/A 626 Large Blend Fund 393 N/A N/A 393 Growth Allocation Fund 153 N/A N/A 153 Moderate Allocation Fund 107 N/A N/A 107 Other 115 N/A N/A 115 Fair value measurements at October 30, 2016 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: Cash and Cash Equivalents $ 23,940 N/A N/A $ 23,940 U.S. Corporate Bonds - 7,110 N/A 7,110 Premier Money Market Fund 4,421 N/A N/A 4,421 Low Duration Bond Fund 1,075 N/A N/A 1,075 Intermediate Term Bond Fund 750 N/A N/A 750 Strategic Income Fund 605 N/A N/A 605 Large Blend Fund 319 N/A N/A 319 Growth Allocation Fund 102 N/A N/A 102 Other 152 N/A N/A 152 Fair value measurements at April 30, 2017 using: Quoted prices in active markets for identical assets Significant other observable inputs Significant unobservable inputs (amounts in thousands) Level 1 Level 2 Level 3 Total Assets: U.S. Corporate Bonds $ - $ 30,831 $ - $ 30,831 Premier Money Market Fund 4,811 N/A N/A 4,811 Low Duration Bond Fund 1,081 N/A N/A 1,081 Intermediate Term Bond Fund 751 N/A N/A 751 Strategic Income Fund 611 N/A N/A 611 Large Blend Fund 365 N/A N/A 365 Growth Allocation Fund 126 N/A N/A 126 Moderate Allocation Fund 88 N/A N/A 88 Other 76 N/A N/A 76

Cash Flow Information (Tables)

Cash Flow Information (Tables)	6 Months Ended
	Oct. 29, 2017
Supplemental Cash Flow Elements [Abstract]
Schedule of Interest and Income Taxes Paid	Interest and income taxes paid are as follows: Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Interest $ 146 $ 45 Income taxes 2,599 3,238

Net Income Per Share (Tables)

Net Income Per Share (Tables)	6 Months Ended
	Oct. 29, 2017
Earnings Per Share [Abstract]
Schedule of Weighted Average Shares Used in the Computation of Basic and Diluted Net Income Per Share	Weighted average shares used in the computation of basic and diluted net income per share follows: Three months ended (amounts in thousands) October 29, 2017 October 30, 2016 Weighted average common shares outstanding, basic 12,440 12,308 Dilutive effect of stock-based compensation 140 199 Weighted average common shares outstanding, diluted 12,580 12,507 Six months ended (amounts in thousands) October 29, 2017 October 30, 2016 Weighted average common shares outstanding, basic 12,420 12,297 Dilutive effect of stock-based compensation 193 198 Weighted average common shares outstanding, diluted 12,613 12,495

Segment Information (Tables)

Segment Information (Tables)	6 Months Ended
	Oct. 29, 2017
Segment Reporting [Abstract]
Schedule of Operating Segments Information	Financial information for the company’s operating segments follows: Three months ended October 29, 2017 October 30, 2016 Net sales: Mattress Fabrics $ 48,601 $ 45,527 Upholstery Fabrics 32,097 29,816 $ 80,698 $ 75,343 Gross profit: Mattress Fabrics $ 9,730 $ 10,756 Upholstery Fabrics 6,074 6,145 $ 15,804 $ 16,901 Mattress Fabrics $ 3,168 $ 3,296 Upholstery Fabrics 3,700 3,652 Total segment selling, general, and administrative expenses 6,868 6,948 Unallocated corporate expenses 2,547 2,654 $ 9,415 $ 9,602 Income from operations: Mattress Fabrics $ 6,562 $ 7,460 Upholstery Fabrics 2,374 2,493 Total segment income from operations 8,936 9,953 Unallocated corporate expenses (2,547 ) (2,654 ) Total income from operations 6,389 7,299 Interest expense (37 ) - Interest income 128 15 Other expense (321 ) (155 ) Income before income taxes $ 6,159 $ 7,159 Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Net sales: Mattress Fabrics $ 97,030 $ 96,057 Upholstery Fabrics 63,200 59,969 $ 160,230 $ 156,026 Gross profit: Mattress Fabrics $ 19,495 $ 22,657 Upholstery Fabrics 12,773 12,664 $ 32,268 $ 35,321 Selling, general, and administrative expenses: Mattress Fabrics $ 6,559 $ 6,795 Upholstery Fabrics 7,511 7,185 Total segment selling, general, and administrative expenses 14,070 13,980 Unallocated corporate expenses 4,846 5,368 $ 18,916 $ 19,348 Income from operations: Mattress Fabrics $ 12,936 $ 15,862 Upholstery Fabrics 5,262 5,479 Total segment income from operations 18,198 21,341 Unallocated corporate expenses (4,846 ) (5,368 ) Total income from operations 13,352 15,973 Interest expense (37 ) - Interest income 259 40 Other expense (674 ) (307 ) Income before income taxes $ 12,900 $ 15,706 Balance sheet information for the company’s operating segments follows: (dollars in thousands) October 29, 2017 October 30, 2016 April 30, 2017 Segment assets: Mattress Fabrics Current assets (1) $ 42,728 $ 38,062 $ 47,038 Non-compete agreement 790 866 828 Customer relationships 638 689 664 Investment in unconsolidated joint venture 1,522 - 1,106 Goodwill 11,462 11,462 11,462 Property, plant and equipment (2) 49,965 43,228 48,916 Total mattress fabrics assets 107,105 94,307 110,014 Upholstery Fabrics Current assets (1) 31,701 26,931 29,021 Property, plant and equipment (3) 2,063 1,480 1,879 Total upholstery fabrics assets 33,764 28,411 30,900 Total segment assets 140,869 122,718 140,914 Non-segment assets: Cash and cash equivalents 15,739 13,910 20,795 Short-term investments (Available for Sale) 2,478 2,430 2,443 Short-term investments (Held-to-Maturity) 4,015 - - Deferred income taxes 491 581 419 Other current assets 2,263 1,675 2,894 Property, plant and equipment (4) 502 829 856 Long-term investments (Held-to-Maturity) 26,853 31,050 30,945 Long-term investments (Rabbi Trust) 6,921 4,994 5,466 Other assets 912 940 902 Total assets $ 201,043 $ 179,127 $ 205,634 Six months ended (dollars in thousands) October 29, 2017 October 30, 2016 Capital expenditures (5): Mattress Fabrics $ 4,364 $ 8,857 Upholstery Fabrics 203 165 Unallocated Corporate 30 62 Total capital expenditures $ 4,597 $ 9,084 Depreciation expense: Mattress Fabrics $ 3,310 $ 3,101 Upholstery Fabrics 403 410 Total depreciation expense $ 3,713 $ 3,511 (1) Current assets represent accounts receivable and inventory for the respective segment. (2) The $50.0 million at October 29, 2017, represents property, plant, and equipment of $35.8 million and $14.2 million located in the U.S. and Canada, respectively. The $43.2 million at October 30, 2016, represents property, plant, and equipment of $28.5 million and $14.7 million located in the U.S. and Canada, respectively. The $48.9 million at April 30, 2017, represents property, plant, and equipment of $34.0 million and $14.9 million located in the U.S. and Canada, respectively. (3) The $2.1 million at October 29, 2017, represents property, plant, and equipment of $1.4 million and $722 located in the U.S. and China, respectively. The $1.5 million at October 30, 2016, represents property, plant, and equipment of $890 and $590 located in the U.S. and China, respectively. The $1.9 million at April 30, 2017, represents property, plant, and equipment of $1.2 million and $655 located in the U.S. and China, respectively. (4) The $502, $829, and $856 at October 29, 2017, October 30, 2016 and April 30, 2017, respectively, represent property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by both the mattress and upholstery fabric segments. Property, plant, and equipment associated with corporate are located in the U.S. (5) Capital expenditure amounts are stated on the accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis.

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
	Oct. 29, 2017
Income Tax Disclosure [Abstract]
Summary of Differences in Income Tax Expense at Federal Income Tax Rate and Effective Income Tax Rate	The following schedule summarizes the factors that contribute to the difference between income tax expense at the federal income tax rate and the effective income tax rate reflected in the consolidated financial statements: 2018 2017 Federal income tax rate 34.0 % 34.0 % Excess income tax benefits related to stock-based compensation (4.3 ) - Tax effects of Chinese foreign exchange (losses) gains (1.5 ) 1.6 U.S. state income tax expense 0.4 0.6 Other 0.5 1.5 29.1 % 37.7 %

Investment in Unconsolidated 37

Investment in Unconsolidated Joint Venture (Tables)	6 Months Ended
	Oct. 29, 2017
Equity Method Investments and Joint Ventures [Abstract]
Summary of Equity Method Investment	The following table summarizes information on assets, liabilities and members’ equity of our equity method investment in CLIH: October 29, April 30, (dollars in thousands) 2017 2017 Total assets $ 3,180 $ 2,258 Total liabilities $ 136 $ 46 Total members’ equity $ 3,044 $ 2,212

Significant Accounting Polici38

Significant Accounting Policies (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income taxes	$ 2,108,000	$ 2,684,000	$ 3,748,000	$ 5,917,000
Accrued expenses and deferred compensation, operating activities			(3,607,000)	(2,469,000)
Common stock surrendered for withholding taxes payable, financing activities			1,147,000	280,000
ASU No. 2016-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income taxes			$ (556,000)
Excess tax benefit related to stock-based compensation, operating activities				167,000
Excess tax benefit related to stock-based compensation, financing activities				167,000
Accrued expenses and deferred compensation, operating activities				280,000
Common stock surrendered for withholding taxes payable, financing activities				$ 280,000

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Detail) - USD ($)		Oct. 29, 2017	Oct. 02, 2017	Jul. 13, 2017	Oct. 03, 2016	Jul. 14, 2016	Jul. 30, 2017	Oct. 29, 2017	Oct. 30, 2016	Sep. 16, 2015
2015 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common stock authorized for issuance										1,200,000
Number of shares available for future equity based grants		902,556						902,556
2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for future equity based grants										0
Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining unrecognized compensation cost		$ 4,300,000						$ 4,300,000
Weighted average period over which unrecognized compensation cost is expected to be recognized								1 year 10 months 25 days
Incentive Stock Option Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted								0
Number of options to purchase common stock outstanding		15,000						15,000
Number of options exercisable		15,000						15,000
Weighted average exercise price for options outstanding		$ 7.08						$ 7.08
Weighted average exercise price for options exercisable		$ 7.08						$ 7.08
Weighted average contractual term for options outstanding		7 months 6 days
Weighted average contractual term for options exercisable		7 months 6 days
Aggregate intrinsic value for options outstanding		$ 373,000						$ 373,000
Aggregate intrinsic value for options exercisable		$ 373,000						373,000
Aggregate intrinsic value for options exercised								$ 14,000	$ 43,000
Number of unvested stock options		0						0
Unrecognized compensation cost related to incentive stock options		$ 0						$ 0
Share-based compensation expense								0	0
Time Vested Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining unrecognized compensation cost		$ 27,000						$ 27,000
Vesting Period								7 months 15 days
Selling, General and Administrative Expenses [Member] | Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense								$ 1,400,000	1,500,000
Selling, General and Administrative Expenses [Member] | Time Vested Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense								17,000	11,000
Selling, General and Administrative Expenses [Member] | Common Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense								$ 159,000	$ 143,000
Employee [Member] | Performance Based Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted	[1],[2]			44,000
Vesting Period	[2]			3 years
Closing price of common stock	[2],[3]			$ 32.50
Employee [Member] | Time Vested Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted				1,200		1,200
Vesting Period				11 months		11 months
Closing price of common stock				$ 32.50		$ 28
Number of shares vested							1,200
Weighted average fair value of vested shares							$ 34,000
Weighted average fair value of vested shares, per share							$ 28
Outside Directors [Member] | Common Stock Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted			4,800		4,800
Vesting Period			0 days		0 days
Closing price of common stock			$ 33.20		$ 29.80
[1]	Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
[2]	Performance-based restricted stock units awarded to key employees.
[3]	Price per share represents the closing price of our common stock on the date of grant.

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Assumptions Used to Determine Fair Value of Performance Based Restricted Stock Units (Detail) - Performance Based Restricted Stock Units [Member] - NEOs [Member]	Jul. 13, 2017$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price of our common stock	$ 32.50
Expected volatility of our common stock	31.00%
Expected volatility of peer companies	16.50%
Risk-free interest rate	1.56%
Dividend yield	1.66%
Correlation coefficient of peer companies	46.00%

Stock-Based Compensation - Su41

Stock-Based Compensation - Summary of Grants of Performance Based Restricted Stock Units Associated with NEOs and Key Employees (Detail) - Performance Based Restricted Stock Units [Member] - $ / shares		Jul. 13, 2017	Jul. 14, 2016	Jul. 15, 2015
NEOs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1],[2]	78,195
Price Per Share	[2],[3]	$ 31.85
Vesting Period	[2]	3 years
Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1],[4]	44,000
Price Per Share	[4],[5]	$ 32.50
Vesting Period	[4]	3 years
NEOs and Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1],[2],[4]		107,880	107,554
Price Per Share	[2],[4],[5]		$ 28	$ 32.23
Vesting Period	[2],[4]		3 years	3 years
[1]	Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
[2]	Performance-based restricted stock units awarded to NEOs.
[3]	Price per share represents the fair market value per share ($0.98 per $1 or a reduction of $0.65 to the closing price of the our common stock) determined using the Monte Carlo simulation model for the market-based total shareholder return component and the closing price of our common stock ($32.50) for the performance-based components of the performance-based restricted stock units granted to our NEOs on July 13, 2017.
[4]	Performance-based restricted stock units awarded to key employees.
[5]	Price per share represents the closing price of our common stock on the date of grant.

Stock-Based Compensation - Su42

Stock-Based Compensation - Summary of Grants of Performance Based Restricted Stock Units Associated with NEOs and Key Employees (Parenthetical) (Detail) - Performance Based Restricted Stock Units [Member] - NEOs [Member]	Jul. 13, 2017$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value adjustment to closing price of common stock, percentage	98.00%
Fair value adjustment to closing price of common stock, per share	$ (0.65)
Closing price of common stock	$ 32.50

Stock-Based Compensation - Su43

Stock-Based Compensation - Summary of Grants of Performance Based Restricted Stock Units Associated with Non-Employee (Detail) - Performance Based Restricted Stock Units [Member] - Non-employee [Member] - $ / shares		Jul. 13, 2017	Jul. 14, 2016	Jul. 15, 2015	Oct. 29, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted Stock Units Awarded	[1]	10,200	11,549	10,364
Vesting Period		3 years	3 years	3 years
Granted on July 13, 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Price Per Share	[2]				$ 31.95
Granted on July 14, 2016 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Price Per Share	[2]				31.95
Granted on July 15, 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Price Per Share	[2]				$ 31.95
[1]	Amounts represent the maximum number of common stock shares that could be earned if certain performance targets are met as defined in the related restricted stock unit agreements.
[2]	The respective grant was unvested at the end of our reporting period. Accordingly, the price per share represents the closing price of our common stock on October 29, 2017, the end of our reporting period.

Stock-Based Compensation - Su44

Stock-Based Compensation - Summary of Vested Performance Based Restricted Stock Units (Detail) - Performance Based Restricted Stock Units [Member] - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
		Oct. 29, 2017	Oct. 30, 2016
NEOs and Key Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock Shares Vested	[1]	102,845	37,192
Weighted Average Fair Value	[1],[2]	$ 1,820	$ 637
Price Per Share	[1],[3]	$ 17.70	$ 17.12
Non-employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common Stock Shares Vested	[4]	16,000	12,000
Weighted Average Fair Value	[2],[4]	$ 520	$ 345
Price Per Share	[4],[5]	$ 32.50	$ 28.77
[1]	NEOs and key employees.
[2]	Dollar amounts are in thousands.
[3]	Price per share represents closing price of our common stock on the date of grant.
[4]	Non-employee
[5]	The respective grant vested during the first quarter of fiscal 2018 or 2017, respectively. Accordingly, the price per share represents the closing price of our common stock on the date the award vested.

Accounts Receivable (Detail)

Accounts Receivable (Detail) - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016	May 01, 2016
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customers	$ 25,593	$ 26,211		$ 20,580
Accounts receivable, net	24,220	24,577	[1]	19,039
Allowance for doubtful accounts [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Valuation allowance, balance	(374)	(414)		(420)	$ (1,088)
Reserve for returns and allowances and discounts [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Valuation allowance, balance	$ (999)	$ (1,220)		$ (1,121)	$ (962)
[1]	Derived from audited financial statements.

Accounts Receivable - Allowance

Accounts Receivable - Allowance for Doubtful Accounts (Detail) - Allowance for doubtful accounts [Member] - USD ($) $ in Thousands	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning balance	$ (414)	$ (1,088)
Provision for bad debts	40	216
Net write-offs, net of recoveries		452
Ending balance	$ (374)	$ (420)

Accounts Receivable - Allowan47

Accounts Receivable - Allowance for Returns and Allowances and Discounts (Detail) - Reserve for returns and allowances and discounts [Member] - USD ($) $ in Thousands	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016
Valuation and Qualifying Accounts Disclosure [Line Items]
Beginning balance	$ (1,220)	$ (962)
Provision for returns, allowances and discounts	(1,330)	(1,620)
Credits issued	1,551	1,461
Ending balance	$ (999)	$ (1,121)

Inventories (Detail)

Inventories (Detail) - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Inventory Disclosure [Abstract]
Raw materials	$ 6,617	$ 6,456		$ 6,128
Work-in-process	2,686	3,095		2,518
Finished goods	40,906	41,931		37,308
Inventories	$ 50,209	$ 51,482	[1]	$ 45,954
[1]	Derived from audited financial statements.

Other Assets (Detail)

Other Assets (Detail) - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Other Assets, Noncurrent [Abstract]
Cash surrender value - life insurance	$ 376	$ 376		$ 358
Non-compete agreement, net	790	828		866
Customer relationships, net	638	664		689
Other	536	526		582
Other assets	$ 2,340	$ 2,394	[1]	$ 2,495
[1]	Derived from audited financial statements.

Other Assets - Narrative (Detai

Other Assets - Narrative (Detail)	6 Months Ended
	Oct. 29, 2017USD ($)Contract	Oct. 30, 2016USD ($)Contract	Apr. 30, 2017USD ($)Contract
Other Assets [Line Items]
Gross carrying amount of non-compete agreement	$ 2,000,000	$ 2,000,000	$ 2,000,000
Gross carrying amount of customer relationships	$ 868,000	$ 868,000	$ 868,000
Number of life insurance contracts owned | Contract	1	1	1
Life insurance contracts, death benefits to insured	$ 1,400,000	$ 1,400,000	$ 1,400,000
Life insurance contracts, cash surrender value	$ 376,000	358,000	376,000
Non-compete Agreement [Member]
Other Assets [Line Items]
Useful life	15 years
Accumulated amortization	$ 1,200,000	1,200,000	1,200,000
Amortization expense	38,000	38,000
Remaining amortization expense for the fiscal year	37,000
Remaining amortization expense for the second fiscal year	75,000
Remaining amortization expense for the third fiscal year	75,000
Remaining amortization expense for the fourth fiscal year	75,000
Remaining amortization expense for the fifth fiscal year	75,000
Remaining amortization expense for the fiscal year thereafter	$ 453,000
Weighted average remaining amortization period	10 years 6 months
Customer Relationships [Member]
Other Assets [Line Items]
Useful life	17 years
Accumulated amortization	$ 230,000	179,000	$ 204,000
Amortization expense	26,000	$ 26,000
Remaining amortization expense for the fiscal year	25,000
Remaining amortization expense for the second fiscal year	51,000
Remaining amortization expense for the third fiscal year	51,000
Remaining amortization expense for the fourth fiscal year	51,000
Remaining amortization expense for the fifth fiscal year	51,000
Remaining amortization expense for the fiscal year thereafter	$ 409,000
Weighted average remaining amortization period	12 years 6 months

Accrued Expenses (Detail)

Accrued Expenses (Detail) - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Payables and Accruals [Abstract]
Compensation, commissions and related benefits	$ 5,399	$ 10,188		$ 7,111
Advertising rebates	650	468		734
Interest	18	51		5
Other accrued expenses	1,297	1,240		1,028
Accrued expenses	$ 7,364	$ 11,947	[1]	$ 8,878
[1]	Derived from audited financial statements.

Lines of Credit - Narrative (De

Lines of Credit - Narrative (Detail)	May 15, 2018USD ($)	Feb. 01, 2018USD ($)	Nov. 01, 2017USD ($)	Oct. 29, 2017USD ($)	Oct. 29, 2017CNY (¥)	Apr. 30, 2017USD ($)	Oct. 30, 2016USD ($)	Aug. 03, 2016USD ($)	Aug. 01, 2016USD ($)
United States [Member] | Third Amendment to Credit Agreement [Member]
Line of Credit Facility [Line Items]
Maximum amount of letters of credit									$ 7,500,000
Letters of credit outstanding, additional amount				$ 3,750,000				$ 5,000,000
United States [Member] | Third Amendment to Credit Agreement [Member] | Scenario, Forecast [Member]
Line of Credit Facility [Line Items]
Automatic reduction of the additional letter of credit	$ 1,250,000	$ 1,250,000	$ 1,250,000
United States [Member] | Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 30,000,000
Interest rate description				Interest was charged at a rate as a variable spread over LIBOR based on our ratio of debt to EBITDA.
Applicable interest rate at end of period				2.69%	2.69%	2.45%	1.98%
Expiration date				Aug. 15, 2018
Reference rate on which the interest rate is based				LIBOR
Percentage of common stock in subsidiary pledge as collateral				65.00%
Outstanding amount				$ 0		$ 0	$ 0
Letters of credit, outstanding amount				250,000		250,000	250,000
China [Member] | Revolving credit agreement [Member]
Line of Credit Facility [Line Items]
Maximum borrowing capacity				$ 6,000,000	¥ 40,000,000
Interest rate description				This agreement has an interest rate determined by the Chinese government
Expiration date				Feb. 15, 2018
Outstanding amount				$ 0		$ 0	$ 0

Fair Value of Financial Instr53

Fair Value of Financial Instruments - Recurring Basis (Detail) - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017	Oct. 30, 2016
U.S. Corporate Bonds [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	$ 30,773	$ 30,831	$ 7,110
Premier Money Market Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	6,153	4,811	4,421
Low Duration Bond Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	1,087	1,081	1,075
Intermediate Term Bond Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	765	751	750
Strategic Income Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	626	611	605
Large Blend Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	393	365	319
Growth Allocation Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	153	126	102
Moderate Allocation Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	107	88
Other [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	115	76	152
Cash and Cash Equivalents [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis			23,940
Quoted prices in active markets for identical assets - Level 1 [Member] | Premier Money Market Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	6,153	4,811	4,421
Quoted prices in active markets for identical assets - Level 1 [Member] | Low Duration Bond Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	1,087	1,081	1,075
Quoted prices in active markets for identical assets - Level 1 [Member] | Intermediate Term Bond Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	765	751	750
Quoted prices in active markets for identical assets - Level 1 [Member] | Strategic Income Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	626	611	605
Quoted prices in active markets for identical assets - Level 1 [Member] | Large Blend Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	393	365	319
Quoted prices in active markets for identical assets - Level 1 [Member] | Growth Allocation Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	153	126	102
Quoted prices in active markets for identical assets - Level 1 [Member] | Moderate Allocation Fund [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	107	88
Quoted prices in active markets for identical assets - Level 1 [Member] | Other [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	115	76	152
Quoted prices in active markets for identical assets - Level 1 [Member] | Cash and Cash Equivalents [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis			23,940
Significant other observable inputs - Level 2 [Member] | U.S. Corporate Bonds [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Assets measured at fair value on a recurring basis	$ 30,773	$ 30,831	$ 7,110

Fair Value of Financial Instr54

Fair Value of Financial Instruments - Narrative (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jan. 29, 2017	Oct. 30, 2016	Oct. 30, 2016	Oct. 29, 2017	Apr. 30, 2017
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments - Available for Sale		$ 2,430,000	$ 2,430,000	$ 2,478,000	$ 2,443,000	[1]
Held to maturity investments		31,000,000	31,000,000
Purchase of long-term investments (Held-To-Maturity)			31,050,000
Held to maturity investments, fair value		31,000,000	31,000,000	30,800,000	30,800,000
Long-term investments (Rabbi Trust)		4,994,000	4,994,000	6,921,000	5,466,000	[1]
U.S. Corporate Bonds [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Held to maturity investments		$ 7,100,000	7,100,000	30,900,000	30,900,000
Purchase of long-term investments (Held-To-Maturity)	$ 23,900,000
U.S. Corporate Bonds [Member] | Minimum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments, maturity period		2 years
U.S. Corporate Bonds [Member] | Maximum [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments, maturity period		2 years 6 months
Short-term Investments [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accumulated unrealized gain (loss) on long-term investments		$ (45,000)	(45,000)	(36,000)	(47,000)
Cash and Cash Equivalents [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Held to maturity investments		23,900,000	23,900,000
Long-term investments (Rabbi Trust) [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accumulated unrealized gain (loss) on long-term investments		$ 1,000	$ 1,000	$ 96,000	$ 43,000
[1]	Derived from audited financial statements.

Cash Flow Information - Interes

Cash Flow Information - Interest and Income Taxes Paid (Detail) - USD ($) $ in Thousands	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Interest	$ 146	$ 45
Income taxes	$ 2,599	$ 3,238

Cash Flow Information - Narrati

Cash Flow Information - Narrative (Detail) - USD ($)	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016
Supplemental Cash Flow Elements [Abstract]
Interest costs	$ 137,000	$ 45,000
Interest cost capitalized	$ 100,000	$ 45,000

Net Income Per Share - Weighted

Net Income Per Share - Weighted Average Shares (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
Earnings Per Share [Abstract]
Weighted average common shares outstanding, basic	12,440	12,308	12,420	12,297
Dilutive effect of stock-based compensation	140	199	193	198
Weighted average common shares outstanding, diluted	12,580	12,507	12,613	12,495

Segment Information - Narrative

Segment Information - Narrative (Detail)	6 Months Ended
	Oct. 29, 2017Segment
Segment Reporting [Abstract]
Number of business segments	2

Segment Information - Financial

Segment Information - Financial Information for Operating Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
Segment Reporting Information [Line Items]
Net sales	$ 80,698	$ 75,343	$ 160,230	$ 156,026
Gross profit	15,804	16,901	32,268	35,321
Selling, general, and administrative expenses	9,415	9,602	18,916	19,348
Income from operations	6,389	7,299	13,352	15,973
Interest expense	(37)		(37)
Interest income	128	15	259	40
Other expense	(321)	(155)	(674)	(307)
Income before income taxes	6,159	7,159	12,900	15,706
Operating Segments [Member]
Segment Reporting Information [Line Items]
Selling, general, and administrative expenses	6,868	6,948	14,070	13,980
Income from operations	8,936	9,953	18,198	21,341
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales	32,097	29,816	63,200	59,969
Gross profit	6,074	6,145	12,773	12,664
Selling, general, and administrative expenses	3,700	3,652	7,511	7,185
Income from operations	2,374	2,493	5,262	5,479
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Net sales	48,601	45,527	97,030	96,057
Gross profit	9,730	10,756	19,495	22,657
Selling, general, and administrative expenses	3,168	3,296	6,559	6,795
Income from operations	6,562	7,460	12,936	15,862
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Selling, general, and administrative expenses	2,547	2,654	4,846	5,368
Income from operations	$ (2,547)	$ (2,654)	$ (4,846)	$ (5,368)

Segment Information - Balance S

Segment Information - Balance Sheet Information by Operating Segments (Detail) - USD ($) $ in Thousands		6 Months Ended
		Oct. 29, 2017	Oct. 30, 2016	Apr. 30, 2017		May 01, 2016
Segment Reporting Information [Line Items]
Non-compete agreement		$ 790	$ 866	$ 828
Customer relationships		638	689	664
Investment in unconsolidated joint venture		1,522		1,106	[1]
Goodwill		11,462	11,462	11,462	[1]
Property, plant and equipment		52,530	45,537	51,651	[1]
Total assets		201,043	179,127	205,634	[1]
Cash and cash equivalents		15,739	13,910	20,795	[1]	$ 37,787
Short-term investments (Available for Sale)		2,478	2,430	2,443	[1]
Short-term investments (Held-to-Maturity)		4,015
Deferred income taxes		491	581	419	[1]
Other current assets		2,263	1,675	2,894	[1]
Long-term investments (Held-to-Maturity)		26,853	31,050	30,945	[1]
Long-term investments (Rabbi Trust)		6,921	4,994	5,466	[1]
Other assets		2,340	2,495	2,394	[1]
Capital expenditures	[2]	4,597	9,084
Depreciation expense		3,713	3,511
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total assets		140,869	122,718	140,914
Operating Segments [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Current assets	[3]	42,728	38,062	47,038
Non-compete agreement		790	866	828
Customer relationships		638	689	664
Investment in unconsolidated joint venture		1,522		1,106
Goodwill		11,462	11,462	11,462
Property, plant and equipment	[4]	49,965	43,228	48,916
Total assets		107,105	94,307	110,014
Capital expenditures		4,364	8,857
Depreciation expense		3,310	3,101
Operating Segments [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Current assets	[3]	31,701	26,931	29,021
Property, plant and equipment	[5]	2,063	1,480	1,879
Total assets		33,764	28,411	30,900
Capital expenditures		203	165
Depreciation expense		403	410
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment	[6]	502	829	856
Cash and cash equivalents		15,739	13,910	20,795
Short-term investments (Available for Sale)		2,478	2,430	2,443
Short-term investments (Held-to-Maturity)		4,015
Deferred income taxes		491	581	419
Other current assets		2,263	1,675	2,894
Long-term investments (Held-to-Maturity)		26,853	31,050	30,945
Long-term investments (Rabbi Trust)		6,921	4,994	5,466
Other assets		912	940	$ 902
Capital expenditures		$ 30	$ 62
[1]	Derived from audited financial statements.
[2]	Capital expenditure amounts are stated on the accrual basis. See Consolidated Statements of Cash Flows for capital expenditure amounts on a cash basis.
[3]	Current assets represent accounts receivable and inventory for the respective segment.
[4]	The $50.0 million at October 29, 2017, represents property, plant, and equipment of $35.8 million and $14.2 million located in the U.S. and Canada, respectively. The $43.2 million at October 30, 2016, represents property, plant, and equipment of $28.5 million and $14.7 million located in the U.S. and Canada, respectively. The $48.9 million at April 30, 2017, represents property, plant, and equipment of $34.0 million and $14.9 million located in the U.S. and Canada, respectively.
[5]	The $2.1 million at October 29, 2017, represents property, plant, and equipment of $1.4 million and $722 located in the U.S. and China, respectively. The $1.5 million at October 30, 2016, represents property, plant, and equipment of $890 and $590 located in the U.S. and China, respectively. The $1.9 million at April 30, 2017, represents property, plant, and equipment of $1.2 million and $655 located in the U.S. and China, respectively.
[6]	The $502, $829, and $856 at October 29, 2017, October 30, 2016 and April 30, 2017, respectively, represent property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by both the mattress and upholstery fabric segments. Property, plant, and equipment associated with corporate are located in the U.S.

Segment Information - Balance61

Segment Information - Balance Sheet Information by Operating Segments (Parenthetical) (Detail) - USD ($) $ in Thousands		Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Segment Reporting Information [Line Items]
Property, plant and equipment		$ 52,530	$ 51,651	[1]	$ 45,537
United States [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		35,800	34,000		28,500
United States [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		1,400	1,200		890
Canada [Member] | Mattress Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		14,200	14,900		14,700
China [Member] | Upholstery Fabrics [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		722	655		590
Unallocated Corporate [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment	[2]	502	856		829
Unallocated Corporate [Member] | United States [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment		$ 502	$ 856		$ 829
[1]	Derived from audited financial statements.
[2]	The $502, $829, and $856 at October 29, 2017, October 30, 2016 and April 30, 2017, respectively, represent property, plant, and equipment associated with unallocated corporate departments and corporate departments shared by both the mattress and upholstery fabric segments. Property, plant, and equipment associated with corporate are located in the U.S.

Income Taxes - Effective Income

Income Taxes - Effective Income Tax Rate - Narrative (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Oct. 29, 2017	Oct. 30, 2016
Income Tax Disclosure [Abstract]
Income taxes	$ 2,108	$ 2,684	$ 3,748	$ 5,917
Effective income tax rate			29.10%	37.70%

Income Taxes - Differences Betw

Income Taxes - Differences Between Income Tax Expense at Federal Income Tax Rate and Effective Income Tax Rate (Detail)	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016
Income Tax Disclosure [Abstract]
Federal income tax rate	34.00%	34.00%
Excess income tax benefits related to stock-based compensation	(4.30%)
Tax effects of Chinese foreign exchange (losses) gains	(1.50%)	1.60%
U.S. state income tax expense	0.40%	0.60%
Other	0.50%	1.50%
Effective income tax rate	29.10%	37.70%

Income Taxes - Deferred Income

Income Taxes - Deferred Income Taxes - Valuation Allowance - Narrative (Detail) - USD ($)	Oct. 29, 2017	Apr. 30, 2017	Oct. 30, 2016
U.S. Tax Authorities and Poland Tax Authorities [Member] | Valuation Allowance, Operating Loss Carryforwards [Member]
Income Taxes [Line Items]
Valuation allowance	$ 632,000	$ 536,000	$ 603,000
U.S. State Tax [Member] | Valuation Allowance, Operating Loss Carryforwards [Member]
Income Taxes [Line Items]
Valuation allowance	554,000	464,000	519,000
Canada and China [Member]
Income Taxes [Line Items]
Valuation allowance	0	0	0
Culp Europe [Member] | Poland [Member] | Valuation Allowance, Operating Loss Carryforwards [Member]
Income Taxes [Line Items]
Valuation allowance	$ 78,000	$ 72,000	$ 84,000

Income Taxes - Deferred Incom65

Income Taxes - Deferred Income Taxes - Undistributed Earnings - Narrative (Detail) - USD ($)	6 Months Ended		12 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Apr. 30, 2017
Income Taxes [Line Items]
Undistributed earnings from our foreign subsidiaries that will not be reinvested indefinitely	$ 145,300,000	$ 138,900,000	$ 146,900,000
Deferred tax liability, undistributed earnings from foreign subsidiaries	322,000	657,000	497,000
U.S. income and foreign withholding taxes	42,400,000	41,400,000	44,000,000
U.S. foreign income tax credits	$ 42,100,000	$ 40,700,000	43,500,000
Unconsolidated Joint Venture [Member] | Haiti [Member]
Income Taxes [Line Items]
Undistributed earnings of foreign subsidiaries to be reinvested indefinitely			$ 1,800,000

Income Taxes - Deferred Incom66

Income Taxes - Deferred Income Taxes - Narrative (Detail) - USD ($)	Oct. 29, 2017	Apr. 30, 2017		Oct. 30, 2016
Income Taxes [Line Items]
Non-current deferred tax asset	$ 491,000	$ 419,000	[1]	$ 581,000
Non-current deferred tax liability	4,641,000	3,593,000	[1]	1,699,000
U.S. Tax Authorities [Member]
Income Taxes [Line Items]
Non-current deferred tax asset				109,000
Non-current deferred tax liability	2,500,000	1,500,000
China [Member]
Income Taxes [Line Items]
Non-current deferred tax asset	491,000	419,000		472,000
Canada [Member]
Income Taxes [Line Items]
Non-current deferred tax liability	$ 2,100,000	$ 2,100,000		$ 1,699,000
[1]	Derived from audited financial statements.

Income Taxes - Uncertainty in I

Income Taxes - Uncertainty in Income Taxes - Narrative (Detail) - USD ($)	6 Months Ended
	Oct. 29, 2017	Apr. 30, 2017	Oct. 30, 2016
Income Taxes [Line Items]
Unrecognized tax benefits	$ 12,600,000	$ 12,200,000	$ 15,100,000
Unrecognized tax benefits that would favorably impact effective income tax rate if recognized	487,000	467,000	3,700,000
Unrecognized tax benefits for which significant change is reasonably possible	12,600,000
Non-current Deferred Income Taxes [Member]
Income Taxes [Line Items]
Unrecognized tax benefits	12,100,000	11,800,000	11,400,000
Income Taxes Payable - Long-Term [Member]
Income Taxes [Line Items]
Unrecognized tax benefits	$ 487,000	$ 467,000	$ 3,700,000
Earliest Tax Year [Member] | United States Federal and State Income Tax [Member]
Income Taxes [Line Items]
Income tax returns, years subject to examination	2,005
Canada [Member]
Income Taxes [Line Items]
Income tax examination, proposed adjustments	$ 0
Canada [Member] | Earliest Tax Year [Member]
Income Taxes [Line Items]
Income tax returns, years subject to examination	2,013
Income tax examination, year under examination	2,013
Canada [Member] | Latest Tax Year [Member]
Income Taxes [Line Items]
Income tax examination, year under examination	2,015
China [Member] | Earliest Tax Year [Member]
Income Taxes [Line Items]
Income tax returns, years subject to examination	2,012
Internal Revenue Service (IRS) [Member]
Income Taxes [Line Items]
Income tax examination, description	The IRS proposed an adjustment approximating $12.5 million of income taxes that relates to our transfer pricing with certain foreign subsidiaries. Management does not agree with the IRS' proposed adjustment and intends to vigorously defend its position.
Income tax examination, proposed adjustments	$ 12,500,000
Internal Revenue Service (IRS) [Member] | Earliest Tax Year [Member]
Income Taxes [Line Items]
Income tax examination, year under examination	2,014
Internal Revenue Service (IRS) [Member] | Latest Tax Year [Member]
Income Taxes [Line Items]
Income tax examination, year under examination	2,016

Statutory Reserves (Detail)

Statutory Reserves (Detail) - Subsidiaries [Member] - China [Member] $ in Millions	6 Months Ended
	Oct. 29, 2017USD ($)
Statutory Reserve [Line Items]
Percentage of net income required to be transferred to a statutory surplus reserve fund	10.00%
Maximum required percentage of statutory surplus reserve fund to registered capital	50.00%
Statutory surplus reserve fund balance	$ 4.4
Percentage of accumulated earnings and profits determined in accordance with PRC accounting rules and regulations	10.00%
Minimum threshold percentage for statutory surplus reserve fund as percentage of registered capital, below which certain capital transactions are prohibited	25.00%

Commitments and Contingencies (

Commitments and Contingencies (Detail) - USD ($)	May 16, 2016	Apr. 30, 2016	Oct. 29, 2017	Apr. 30, 2017	Oct. 30, 2016
Commitments and Contingencies Disclosure [Line Items]
Accounts payable for capital expenditures			$ 3,200,000	$ 6,100,000	$ 3,000,000
Buildings and Improvements [Member]
Commitments and Contingencies Disclosure [Line Items]
Amount financed for construction of building			2,700,000	5,100,000	$ 1,500,000
Amount financed for construction of building required to be paid for remainder of fiscal 2018			1,300,000
Amount financed for construction of building required to be paid in fiscal 2019			1,400,000
Mattress Fabrics [Member] | Capital Addition Purchase Commitments [Member]
Commitments and Contingencies Disclosure [Line Items]
Open purchase commitments			3,800,000
Mattress Fabrics [Member] | Capital Addition Purchase Commitments [Member] | Buildings and Improvements [Member]
Commitments and Contingencies Disclosure [Line Items]
Open purchase commitments			$ 2,700,000
Contractual obligation, current cost	$ 11,300,000
Contractual obligation paid		$ 1,900,000		$ 4,300,000
Contractual obligation due in fiscal 2018	3,700,000
Contractual obligation due in fiscal 2019	1,400,000
Mattress Fabrics [Member] | Capital Addition Purchase Commitments [Member] | Buildings and Improvements [Member] | London Interbank Offered Rate (LIBOR) [Member]
Commitments and Contingencies Disclosure [Line Items]
Percentage rate added to variable rate			2.25%
Variable interest rate			30 day LIBOR rate
Mattress Fabrics [Member] | Capital Addition Purchase Commitments [Member] | Buildings and Improvements [Member] | Letter of Credit [Member]
Commitments and Contingencies Disclosure [Line Items]
Letter of credit	$ 5,000,000
Unused fee calculated on letter of credit	0.10%

Investment in Unconsolidated 70

Investment in Unconsolidated Joint Venture - Narrative (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Oct. 29, 2017	Oct. 29, 2017	Apr. 30, 2017		Jan. 01, 2017
Schedule of Equity Method Investments [Line Items]
Loss from investment in unconsolidated joint venture	$ (75,000)	$ (193,000)
Investment in unconsolidated joint venture	$ 1,522,000	$ 1,522,000	$ 1,106,000	[1]
CLIH [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage	50.00%	50.00%			50.00%
Unconsolidated joint venture, net loss		$ (386,000)
Loss from investment in unconsolidated joint venture		(193,000)
Investment in unconsolidated joint venture	$ 1,500,000	$ 1,500,000	$ 1,100,000
[1]	Derived from audited financial statements.

Investment in Unconsolidated 71

Investment in Unconsolidated Joint Venture - Summary of Equity Method Investment (Detail) - CLIH [Member] - USD ($) $ in Thousands	Oct. 29, 2017	Apr. 30, 2017
Schedule of Equity Method Investments [Line Items]
Total assets	$ 3,180	$ 2,258
Total liabilities	136	46
Total members' equity	$ 3,044	$ 2,212

Common Stock Repurchase Progr72

Common Stock Repurchase Program (Detail) - Common Stock Repurchase Program June 15, 2016 [Member] - Common Stock [Member] - USD ($)	6 Months Ended
	Oct. 29, 2017	Oct. 30, 2016	Jun. 15, 2016
Stockholders Equity Note [Line Items]
Authorization amount for repurchase of common stock			$ 5,000,000
Common stock repurchased	0	0
Remaining authorized repurchase amount	$ 5,000,000

Dividend Program (Detail)

Dividend Program (Detail) - USD ($) $ / shares in Units, $ in Thousands	Nov. 30, 2017	Oct. 29, 2017	Oct. 30, 2016
Dividends [Line Items]
Cash dividends paid		$ 4,603	$ 4,307
Special Dividend [Member]
Dividends [Line Items]
Cash dividends paid		$ 2,600	$ 2,500
Cash dividend payment, per share		$ 0.21	$ 0.21
Quarterly Dividend [Member]
Dividends [Line Items]
Cash dividend declared, per share		$ 0.08
Cash dividends paid		$ 2,000	$ 1,800
Cash dividend payment, per share		$ 0.08	$ 0.07
Subsequent Event [Member] | Quarterly Dividend [Member]
Dividends [Line Items]
Increase in cash dividend, percentage	12.50%
Cash dividend declared, per share	$ 0.09
Date of payment to shareholders entitled to dividends	Jan. 16, 2018
Date of record of shareholders entitled to dividends	Jan. 2, 2018